UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2014
¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 333-150954
GUARDIAN 8 HOLDINGS
(Exact name of registrant as specified in its charter)
Nevada
|
26-0674103
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
7432 East Tierra Buena Lane
Suite 102
Scottsdale, Arizona
|
85260
|
(Address of principal executive offices)
|
(Zip Code)
|
(877) 659-6007
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ¨
|
Accelerated filer ¨
|
|
|
Non-accelerated filer ¨ (Do not check if a smaller reporting company)
|
Smaller reporting company x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
The number of shares of Common Stock, $0.001 par value, outstanding on November 10, 2014, was 40,892,560, not including 753,191 shares authorized but unissued.
Part I - Financial Information
|
Page
|
|
|
|
Item 1.
|
|
1
|
Item 2.
|
|
21
|
Item 3.
|
|
30
|
Item 4.
|
|
30
|
|
|
|
Part II - Other Information
|
|
|
|
|
Item 1.
|
|
31
|
Item 1A.
|
|
31
|
Item 2.
|
|
31
|
Item 3.
|
|
31
|
Item 4.
|
|
31
|
Item 5.
|
|
32
|
Item 6.
|
|
34
|
|
|
38
|
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
GUARDIAN 8 HOLDINGS
Condensed Consolidated Balance Sheets
(Unaudited)
|
|
September 30, 2014
|
|
|
December 31, 2013
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
$ |
1,854,092 |
|
|
$ |
305,649 |
|
Accounts receivable, net of allowance for doubtful accounts of
$4,978 as of September 30, 2014 and $952 December 31, 2013
|
|
|
6,964 |
|
|
|
3,767 |
|
|
|
|
541,940 |
|
|
|
143,302 |
|
|
|
|
46,261 |
|
|
|
195,810 |
|
|
|
|
48,278 |
|
|
|
138,262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
851,396 |
|
|
|
41,022 |
|
Finished goods in transit
|
|
|
358,720 |
|
|
|
- |
|
Finished goods on consignment
|
|
|
12,585 |
|
|
|
4,216 |
|
|
|
|
3,720,236 |
|
|
|
832,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed assets, net of accumulated depreciation of $97,855 and $41,931
as of September 30, 2014 and December 31, 2013
|
|
|
264,477 |
|
|
|
220,652 |
|
|
|
|
|
|
|
|
|
|
Website, net of accumulated amortization of $23,434 and $18,226
as of September 30, 2014 and December 31, 2013
|
|
|
- |
|
|
|
5,207 |
|
|
|
|
|
|
|
|
|
|
Patent, net of accumulated amortization of $4,410 and $3,547
as of September 30, 2014 and December 31, 2013
|
|
|
15,447 |
|
|
|
16,310 |
|
Total property and equipment
|
|
|
279,924 |
|
|
|
242,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid loan costs, net of current portion
|
|
|
91,185 |
|
|
|
|
|
|
|
|
6,600 |
|
|
|
- |
|
|
|
|
4,580 |
|
|
|
- |
|
|
|
|
102,365 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
4,102,525 |
|
|
$ |
1,074,197 |
|
Condensed Consolidated Balance Sheets
(Unaudited)
|
|
|
|
|
|
|
Liabilities and Stockholders’ Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$ |
174,310 |
|
|
$ |
218,266 |
|
|
|
|
2,563 |
|
|
|
1,388 |
|
|
|
|
28,311 |
|
|
|
23,737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
7,759 |
|
|
|
39,133 |
|
|
|
|
183,254 |
|
|
|
3,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
1,023,933 |
|
|
|
|
- |
|
|
|
100,000 |
|
Total current liabilities
|
|
|
396,197 |
|
|
|
1,409,482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible senior secured debentures, net of discount
of $1,321,263 at September 30, 2014 and $0 at December 31, 2013
|
|
|
5,678,737 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value, 10,000,000 shares authorized;
no shares issued and outstanding
|
|
|
- |
|
|
|
- |
|
Common stock, $0.001 par value, 100,000,000 shares authorized;
issued and outstanding of 40,842,560 and 37,274,292
at September 30, 2014 and December 31, 2013
|
|
|
40,842 |
|
|
|
37,273 |
|
Common stock owed but not issued: 470,605 and 2,855,979
at September 30, 2014 and December 31, 2013
|
|
|
471 |
|
|
|
2,856 |
|
|
|
|
9,231,917 |
|
|
|
6,629,143 |
|
|
|
|
(11,245,639 |
) |
|
|
(7,004,557 |
) |
Total stockholders’ deficit
|
|
|
(1,972,409 |
) |
|
|
(335,285 |
) |
Total liabilities and stockholders’ deficit
|
|
$ |
4,102,525 |
|
|
$ |
1,074,197 |
|
The accompanying notes are an integral part of the consolidated financial statements.
GUARDIAN 8 HOLDINGS
Condensed Consolidated Statement of Operations
(Unaudited)
|
|
For the Three
|
|
|
For the Three
|
|
|
For the Nine
|
|
|
For the Nine
|
|
|
|
Months Ended
|
|
|
Months Ended
|
|
|
Months Ended
|
|
|
Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2014
|
|
|
2013
|
|
|
2014
|
|
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
20,334 |
|
|
$ |
22,527 |
|
|
$ |
39,346 |
|
|
$ |
25,651 |
|
|
|
|
13,397 |
|
|
|
5,720 |
|
|
|
27,501 |
|
|
|
6,696 |
|
|
|
|
6,937 |
|
|
|
16,807 |
|
|
|
11,845 |
|
|
|
18,955 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
24,858 |
|
|
|
16,443 |
|
|
|
68,001 |
|
|
|
33,842 |
|
General and administrative expenses
|
|
|
1,184,489 |
|
|
|
860,148 |
|
|
|
2,973,393 |
|
|
|
2,105,393 |
|
|
|
|
1,209,347 |
|
|
|
876,591 |
|
|
|
3,041,394 |
|
|
|
2,139,235 |
|
|
|
|
(1,202,410 |
) |
|
|
(859,784 |
) |
|
|
(3,029,549 |
) |
|
|
(2,120,280 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,262 |
|
|
|
- |
|
|
|
1,999 |
|
|
|
- |
|
|
|
|
(572,155 |
) |
|
|
(18,195 |
) |
|
|
(1,213,532 |
) |
|
|
(40,058 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,773,303 |
) |
|
|
(877,979 |
) |
|
|
(4,241,082 |
) |
|
|
(2,160,338 |
) |
Provision for income tax expense
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
$ |
(1,773,303 |
) |
|
$ |
(877,979 |
) |
|
$ |
(4,241,082 |
) |
|
$ |
(2,160,338 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share - basic and diluted
|
|
$ |
(0.04 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.07 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic and diluted
|
|
|
41,172,560 |
|
|
|
34,857,006 |
|
|
|
40,806,423 |
|
|
|
32,383,557 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Guardian 8 Holdings
Condensed Consolidated Statement of Stockholders’ Equity
For the Nine Months Ended September 30, 2014 and the Year Ended December 31, 2013
(Unaudited)
|
|
Common Stock Issued
|
|
|
Common Stock Owed but Not Issued
|
|
|
Paid in
|
|
|
Accumulated
|
|
|
Total Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock previously owed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for director fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock sold for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discounts on notes payable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock previously owed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discounts on notes payable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discounts on convertible debentures
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan fees paid in conjunction with warrants granted to placement agent in convertible debenture offering
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss for the nine months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
Guardian 8 Holdings
Condensed Consolidated Statement of Cash Flows
(Unaudited)
|
|
For the Nine Months Ended
|
|
|
For the Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2014
|
|
|
2013
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile net loss to net cash (used) from operating activities:
|
|
|
|
|
|
|
|
|
Stock issued for services
|
|
|
|
|
|
|
|
|
Stock issued for compensation
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
Amortization of discount on notes payable
|
|
|
|
|
|
|
|
|
Amortization of discount on convertible debentures
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Change in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
) |
Rent and security deposits
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used) by operating activities
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
|
|
|
|
|
|
Net cash (used) by investing activities
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from common stock sales, net of private placement fees
|
|
|
|
|
|
|
|
|
Proceeds from notes payable, related parties
|
|
|
|
|
|
|
|
|
Proceeds from notes payable, unrelated parties
|
|
|
|
|
|
|
|
|
Proceeds from bank line of credit
|
|
|
|
|
|
|
|
|
Proceeds from convertible senior secured debentures
|
|
|
|
|
|
|
|
|
Repayment of notes payable, related parties
|
|
|
|
|
|
|
|
|
Repayment of notes payable, unrelated parties
|
|
|
|
|
|
|
|
|
Repayment of bank line of credit
|
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash financing activity:
|
|
|
|
|
|
|
|
|
Loan fees paid in conjunction with warrants granted to placement agent in convertible debenture offering
|
|
|
|
|
|
|
|
|
Stock issued for services
|
|
|
|
|
|
|
|
|
Number of shares issued for services
|
|
|
|
|
|
|
|
|
Stock issued for compensation
|
|
|
|
|
|
|
|
|
Number of shares issued for compensation
|
|
|
|
|
|
|
|
|
Discount on notes payable
|
|
|
|
|
|
|
|
|
Notes payable converted to common stock
|
|
|
|
|
|
|
|
|
Shares issued for notes payable converted
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
Guardian 8 Holdings
Notes to Condensed Consolidated Financial Statements
Note 1 - Company Organization and Summary of Significant Accounting Policies
Organization
Guardian 8 Corporation (“Guardian 8”) was incorporated in Nevada on June 8, 2009 as Guardian 6 Corporation. In August of 2009, the Company changed its name to Guardian 8 Corporation. The Company’s principle offices are located in Scottsdale, Arizona.
Effective November 30, 2010, we merged with Global Risk Management & Investigative Solutions (“Global Risk”), a public company with its common stock registered with the United States Securities and Exchange Commission. The Company merged into a newly formed wholly owned subsidiary of Global Risk, with the Company being the surviving corporation. Post-merger, Global Risk changed its name to Guardian 8 Holdings.
Basis of presentation
Effective July 1, 2013 the Company transitioned from reporting as a development stage entity to an operating entity as revenues became sustainable with product sales.
Principles of consolidation
For the three and nine months ended September 30, 2014 and 2013, and for the year ended December 31, 2013, the Company was consolidated with its wholly-owned subsidiary, Guardian 8 Corporation. All material intercompany transactions and accounts have been eliminated.
Cash and cash equivalents
Cash and cash equivalents include all cash balances in non-interest bearing accounts and money-market accounts. The Company places its temporary cash investments with quality financial institutions. At times such investments may be in excess of Federal Deposit Insurance Corporation (FDIC) insurance limit. The Company does not believe it is exposed to any significant credit risk on cash and cash equivalents. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. As of September 30, 2014 and December 31, 2013, there were cash equivalents of $1,854,092 and $305,649 respectively.
Accounts receivable
Accounts receivable are carried on a gross basis, with no discounting, less the allowance for doubtful accounts. Management estimates the allowance for doubtful accounts based on existing economic conditions, the financial conditions of the customers, and the amount and the age of past due accounts. Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the allowance for doubtful accounts only after all collection attempts have been exhausted. Allowance for doubtful accounts are calculated on the historical write-off of doubtful accounts of the individual subsidiaries. Invoices are generally considered a doubtful account if no payment has been made in the past 90 days. We review these policies on a quarterly basis, and based on these reviews, we believe we maintain adequate reserves.
Inventories
Inventories are priced at the lower of cost, determined on a first-in, first-out basis, or market. Inventories include purchase prices and the cost of transporting the inventory to our warehouse.
Inventory obsolescence is examined on a regular basis. Currently we have no obsolete inventory.
Revenue recognition
Revenues are recognized in accordance with ASC subtopic 605-10, “Revenue Recognition”. The company recognizes revenue from sales of product upon delivery to its customers where the fee is fixed or determinable, and collectability is probable. Cash payments received in advance are recorded as deferred revenue. Extended warranties are recorded as deferred revenue and amortized according to the number of months in service.
Warranty
The Company offers a 90-day limited warranty on its core product with an opportunity to purchase a one year limited extended warranty on the device. The extended warranty covers the estimated handling and repair costs and profit. Revenue derived from the sale of extended warranties are deferred and amortized over the duration of the warranty period. During the nine months ended September 30, 2014 and year ended December 31, 2013, the Company recorded $2,563 and $1,388 as deferred revenue, and had related warranty expense of $955 and $0, respectively.
Research and development costs
The Company expenses all costs of research and development as incurred. Research and development expenses included in general and administrative expenses totaling $244,794 and $543,779 for the nine months ended September 30, 2014 and 2013 respectively.
Use of estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Property and equipment
Property and equipment are stated at cost. Major improvements are charged to the asset accounts while replacements, maintenance and repairs which do not improve or extend the lives of respective assets are expensed.
The Company depreciates its property and equipment for the financial reporting purposes using the straight-line method based on the following useful lives of the assets:
Equipment
|
2 years
|
Tooling
|
10 years
|
Computer equipment
|
3 years
|
Leasehold improvements
|
Life of lease
|
Furniture and fixtures
|
5 years
|
Warehouse equipment
|
10 years
|
Fair value of financial instruments
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014 and December 31, 2013. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, accounts receivable, accounts payable and amounts due to related parties. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand. See Note 13 for further details.
Impairment of long-lived assets
ASC 360, “Accounting for the Impairment of Long-Lived Assets to be Disposed Of”, requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the carrying value of an asset by estimating the future new cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value. The Company did not have impaired assets during the nine months ended September 30, 2014 and 2013.
Net loss per share
Net Loss per share is provided in accordance with ASC 260-10, “Earnings Per Share” that requires the reporting of both basic and diluted earnings (loss) per share. Basic earnings (loss) per share is computed by dividing the earnings (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In accordance with ASC 260-10, any anti-dilutive effects on net income (loss) per share are excluded. For the nine months ended September 30, 2014 and 2013, the denominator in the diluted earnings per share computation is the same as the denominator for basic earnings per share due to the anti-dilutive effect of the warrants on the Company’s net loss. Diluted earnings (loss) per share is not presented since the effect would be anti-dilutive. Potential common shares as of September 30, 2014 that have been excluded from the computation of diluted net loss per share amounted to 21,414,621 from warrants. Potential common shares as of September 30, 2013 that have been excluded from the computation of net loss per share could be as many as 7,270,560 shares from warrants.
Income taxes
The Company follows ASC subtopic 740-10, “Accounting for Income Taxes”, for recording the provision for income taxes. ASC 740-10 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. See Note 14 for further details.
Recent pronouncements
The Company has evaluated all new accounting pronouncements as of the issue date of these financial statements and has determined that none have or will have a material impact on the financial statements or disclosures.
Note 2 - Going Concern
The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles and under the assumption that the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2014, the Company has an accumulated deficit of $11,245,639.
The Company’s activities since inception have been financially sustained by issuance of common stock and loans. The Company intends to raise additional funds to continue its operations through contributions from the current shareholders and stock issuance to other investors and has issued convertible senior secured debentures.
The ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital from the sale of common stock, loans and, ultimately, the achievement of significant operating revenues. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to recover the value of its assets or satisfy its liabilities.
Note 3 - Prepaid loan costs
During the year ended December 31, 2013, the Company issued notes payable that include a three-year warrant for each $1.00 of principal covered in the notes. The warrants are exercisable at $0.40 per share (See Note 7). The warrants issued were valued
using the Black-Scholes option pricing model and bifurcated out of the note proceeds and recorded as additional paid in capital in the amount of $296,524. As of September 30, 2014, the loan costs were fully amortized.
During the three months ended March 31, 2014, the Company issued notes payable that included a three-year warrant for each $1.00 of principal covered in the notes. The warrants are exercisable at $0.50 per share (See Note 7). The warrants were valued using the Black-Scholes option pricing model and bifurcated out of the note proceeds and recorded as additional paid in capital in the amount of $154,881. As of September 30, 2014, the loan costs were fully amortized.
On May 27, 2014, the Company issued convertible senior secured debentures (See Note 8). From these debentures, the Company incurred loan costs in the amount of $632,786, which are being amortized over eighteen months, which is the period for which the debentures are due. As of September 30, 2014, the balance on these loan costs was $492,167.
On June 2, 2014, the Company issued convertible senior secured debentures (See Note 8). From these debentures, the Company incurred loan costs in the amount of $177,153, which are being amortized over eighteen months, which is the period for which the debentures are due. As of September 30, 2014, the balance on these loan costs was $140,958.
Note 4 - Property and equipment
Property and equipment consists of the following:
|
|
September 30,
2014
|
|
|
December 31,
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less accumulated depreciation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 5 - Deposits on Inventory and Inventory in Transit
As of September 30, 2014 the Company pre-paid $406,998 as deposits on finished personal security device inventory. This inventory is scheduled to arrive by December 31, 2014.
Note 6 - Bank line of credit
On January 17, 2014, the Company entered into a revolving line of credit agreement with Cornerstone Bank, N.A. The agreement provided for an aggregate of up to $700,000, which was increased to $900,000 on April 28, 2014, at any time outstanding pursuant to a revolving line of credit and matures on January 16, 2015. The agreement was secured by inventory, work in process, accounts receivable, a letter of credit, and was personally guaranteed by the Company’s Chief Executive Officer/President. Borrowings bear interest at 6% per annum, with monthly interest payments to be paid by the Company.
As part of the agreement, the Company entered into a Letter of Credit Rights Control Agreement with F&M Bank & Trust Company. Per this agreement, if the Company were to default on the line of credit, F&M Bank & Trust Company would then be held liable to Cornerstone Bank, N.A. for the payment of the line of credit. In addition, the Company would then owe the amount disbursed to F&M Bank & Trust Company. As of September 30, 2014, the bank line of credit was fully paid.
Note 7 - Notes payable
On January 1, 2013, the Company had notes payable from related parties, totaling $200,000. These notes were originally due in 2012, but subsequently extended into 2013. The notes bear interest at a rate of 12% per annum.
On January 24, 2013, the Company received a note payable from the CEO and president of the Company in the amount of $50,000. The note was unsecured, bearing interest at 12% per annum and was payable on September 1, 2013.
On March 6, 2013, the Company received a note payable from the CEO and president of the Company in the amount of $100,000. The note was unsecured, bearing interest at 12% per annum and was payable on September 1, 2013.
On March 6, 2013, the Company received $50,000 from a director of the Company in the form of an unsecured 90-day promissory note. The note was unsecured, bearing interest at 12% per annum and was payable on September 1, 2013.
On March 26, 2013, the Company received $50,000 from a director of the Company in the form of an unsecured 90-day promissory note. The note was unsecured, bearing interest at 12% per annum and was payable on September 1, 2013.
On August 12, 2013, the Company received a note payable from the CEO and president of the Company in the amount of $50,000. The note was unsecured, bearing interest at 12% per annum and was payable on November 30, 2013.
On August 26, 2013, the Company received a note payable from the CEO and president of the Company in the amount of $150,000. The note was unsecured, bearing interest at 12% per annum and was payable on November 30, 2013.
On September 1, 2013, the Company had a total of $615,000 of the original $650,000 in notes payable outstanding to its CEO and directors, with an additional $33,933 owed in accrued interest. This debt, previously due on September 1, 2013 through November 30, 2013, was exchanged for three new unsecured notes payable totaling $648,933. Each of these notes were to mature on April 30, 2014, bearing interest at 12% per annum, and included a three-year warrant for every $1.00 of principal amount of each note. The warrants were exercisable at $0.40 per share. The notes and related accrued interest were paid off as of September 30, 2014.
On September 1, 2013 the Company received a note payable in the amount of $45,000 from a related party in exchange for outstanding invoices owed for engineering services provided in the first nine months of the year. The note was unsecured, bearing interest at 12% per annum, is payable on April 30, 2014, and includes a three-year warrant for each $1.00 of principal included in the note. The warrants are exercisable at $0.40 per share. The note and related accrued interest were paid off as of September 30, 2014.
On September 18, 2013, the Company received a note payable from the CEO and president of the Company in the amount of $50,000. The note was unsecured, bearing interest at 12%, was payable on April 30, 2014, and includes a three-year warrant for each $1.00 of principal included in the note. The warrants are exercisable at $0.40 per share. The note and related accrued interest were paid off as of September 30, 2014.
On September 19, 2013, the Company issued a note payable from a related party in the amount of $30,000. The note was unsecured, bearing interest at 12%, was payable on April 30, 2014, and includes a three-year warrant for each $1.00 of principal
included in the note. The warrants are exercisable at $0.40 per share. The note and related accrued interest were paid off as of September 30, 2014.
On September 19, 2013, the Company issued a note payable from a related party in the amount of $250,000. The note was unsecured, bearing interest at 12%, was payable on April 30, 2014, and included a three-year warrant for each $1.00 of principal included in the note. The warrants were exercisable at $0.40 per share. The note and related accrued interest were paid off as of September 30, 2014.
On September 30, 2013, the Company received a note payable in the amount of $100,000. The note was unsecured, bears interest at 12%, was payable on April 30, 2014, and included a three-year warrant for each of $1.00 of principal included in the note. The warrants were exercisable at $0.40 per share. The note and related accrued interest were paid off as of September 30, 2014.
As of December 31, 2013, the Company had notes payable of $1,123,933 and accrued interest of $42,158. All amounts were due within twelve months. The Company also recognized $296,524 of expense associated with the convertible features of the notes payable issued during the year ended December 31, 2013. As noted above, the balances outstanding inclusive of all accrued interest from these notes were paid in full as of September 30, 2014.
On February 12, 2014, the Company received a note payable in the amount of $50,000 from a related party. The note was unsecured, bearing interest at 12%, was payable on July 15, 2014, and included a three-year warrant for each of $1.00 of principal included in the note. The warrants were exercisable at $0.50 per share. The note and related accrued interest were paid off as of September 30, 2014.
On February 24, 2014, the Company received a note payable in the amount of $25,000 from a related party. The note was unsecured, bearing interest at 12%, was payable on July 15, 2014, and included a three-year warrant for each of $1.00 of principal included in the note. The warrants were exercisable at $0.50 per share. The note and related accrued interest were paid off as of September 30, 2014.
On February 24, 2014, the Company received a note payable in the amount of $400,000 from a related party. The note was unsecured, bearing interest at 12%, was payable on July 15, 2014, and included a three-year warrant for each of $1.00 of principal included in the note. The warrants were exercisable at $0.50 per share. The note and related accrued interest were paid off as of September 30, 2014.
On February 24, 2014, the Company received a note payable in the amount of $25,000 from an unaffiliated company. The note was unsecured, bearing interest at 12%, was payable on July 15, 2014, and included a three-year warrant for each of $1.00 of principal included in the note. The warrants were exercisable at $0.50 per share. The note and related accrued interest were paid off as of September 30, 2014.
Note 8 - Convertible Senior Secured Debentures
The Company issued the following convertible Senior Secured Debentures:
|
|
1 Closing
|
|
|
2nd Closing
|
|
1. Date of issuance
|
|
May 27, 2014
|
|
|
June 2, 2014
|
|
|
|
|
|
|
|
|
2. Gross amount of debentures
|
|
$
|
5,250,000
|
|
|
$
|
1,750,000
|
|
|
|
|
|
|
|
|
|
|
3. Term
|
|
18 Months
Due November 30, 2015
|
|
|
18 Months
Due November 30, 2015
|
|
|
|
|
|
|
|
|
|
|
4. Interest rate
|
|
8% from May 27, 2014
|
|
|
8% from June 2, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
1st Closing |
|
|
2nd Closing |
|
5. Class C warrants to debenture holders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number issued
|
|
|
5,250,000
|
|
|
|
1,750,000
|
|
Strike price per share
|
|
$
|
0.60
|
|
|
$
|
0.60
|
|
Term
|
|
5 years
|
|
|
5 years
|
|
6. Conversion Rights
The debentures may be converted by each buyer commencing on the 91st day following closing and through maturity, either in whole or in part, up to the full principal amount and accrued interest thereunder into shares of common stock at $0.50 per share.
The Company may force conversion of the debentures into shares of common stock at $0.50 per share, either in whole or in part, if the closing sale price of shares of common stock during any ten consecutive trading days has been at or above $1.00 per share.
In the event the average closing price of the common stock for the ten trading days immediately preceding, but not including, the maturity date of the debentures is equal to or greater than $0.80, then on the maturity date, the buyers must convert all remaining principal due under the debentures.
Upon conversion of the debentures, an additional Class C Warrant will be issued under the same terms and same amount as the warrants issued in the debenture sale.
7. Security of Debentures. The debentures are guaranteed, pursuant to “Secured Guaranty” and “Pledge and Security Agreement by Guardian 8 Corporation and secured interest in all of the assets of the company and Guardian 8 Corporation.
8. Registration Rights. The Company has agreed to file a “resale” registration statement with the Securities and Exchange Commission covering all shares of common stock underlying the debentures and Class C warrants within 90 days of the final closing, on or before August 31, 2014, and to maintain the effectiveness of the registration statement for five years, or until all securities have been sold or are otherwise able to be sold pursuant to Rule 144. The Registrant has agreed to use its reasonable best efforts to have the registration statement declared effective within 120 days of the filing date. The Company is obligated to pay to investors liquidated damages equal to 1.0% per month in cash for every thirty day period up to a maximum of six percent, (i) that the registration statement has not been filed after the filing date, (ii) following the effectiveness date that the registration statement has not been declared effective; and (iii) as otherwise set forth in the financing agreements. On October 29, 2014 the Company’s registration statement was declared effective.
9. Valuation of Warrants
The warrants issued with the debentures were valued using the Black-Scholes option pricing model and bifurcated out of the note proceeds and recorded as additional paid in capital in the amounts of $1,274,074 for the first closing and $424,692 for the second closing. The assumptions used in the pricing model were: term 5 years, risk free interest rate 1.56% - 1.60%, and volatility 99%. A $1,698,766 discount on the debenture was recorded and is being amortized into interest expense over the eighteen month life of the debenture using the interest method.
As of September 30, 2014, $377,503 was amortized into interest expense and the remaining discounts were $1,321,263. $295,000 of the debentures were to related parties.
Note 9 - Patents
In June of 2009, concurrent with the Company’s incorporation, one of its officers and directors, agreed to transfer all rights, title and interest in the patent he held for a personal security device. The cost of the patent is being amortized over the 20-year life of the patent.
The Company hired a patent attorney specializing in products for the security industry to assist in filing additional utility and technology patents for its new enhanced non-lethal products. During the nine months ended September 30, 2014, the costs paid to this attorney for the filings, drawings, and research totaled $11,533. These costs have been capitalized and are being amortized over the 20-year life of the patents once issued and placed into service.
Note 10 - Stockholders’ equity
On January 1, 2013, there were 30,874,508 common shares issued and outstanding, 1,225,994 common shares owed but not issued, and no preferred shares issued. As of March 31, 2013, all of these shares were issued to their respective parties.
During the quarter ended March 31, 2013, three employees vested shares of common stock in accordance with their employment agreements (see Note 15). The first was the CEO/Director, vesting 150,000 shares of common stock, which were valued at market price of $54,000. The other two issuances were for the Company’s Chief Operating Officer and Vice President of Customer Service, both of which achieved milestones predicated by their employment agreements. The total number of shares vested for these two officers totaled 89,200 shares of common stock that were valued at market price of $37,464.
On January 23, 2013, the Company authorized the issuance of 330,000 shares of common stock in exchange for services, 180,000 of these shares were earned and expensed in the year ended December 31, 2012. The remaining 150,000 shares were valued at the market price at the date of authorization for a total expense of $58,500.
On January 23, 2013, the Company conducted the third and final closing under a private placement offering, selling 225,000 units for $90,000 ($45,000 and 112,500 shares of which was received and accounted for in the year ended December 31, 2012). The shares were sold for $0.40 each and came with two warrants. The Class A warrants have an exercise price of $0.55 and a term of three years. The Class B warrants have an exercise price of $0.75 and a term of five years. All of the shares sold were issued as of December 31, 2013.
On March 6, 2013, the Company issued 10,000 shares of restricted common stock for $4,000 to a consultant.
On March 19, 2013, the Company conducted the first closing under a private placement offering selling 750,000 units for $300,000 to three accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid Finance 500, Inc., a registered broker/dealer and managing dealer for the offering, selling commissions in the amount of $39,000 and is obligated to issue 112,500 warrants to Finance 500. Each warrant will entitle Finance 500, or its assignees, to purchase one share of the Company’s common stock at $0.40 per share for ten years. The Company also incurred $46,121 of expenses associated with this offering, for a net amount of $253,879.
On April 30, 2013 the Company completed a closing under a private placement offering selling 187,500 units for $75,000 to three accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for a $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid selling commissions to a registered broker/dealer and managing dealer for the offering in the amount of $9,750. The Company incurred $11,324 of total expenses associated with this offering, for a net amount of $63,675, and is obligated to issue 28,125 warrants to the registered broker in association with the sale.
On April 30, 2013 the Company issued 12,500 shares of common stock for cash in the amount of $5,000.
On May 6, 2013, the Company conducted a closing under a private placement offering selling 625,000 units for $250,000 to an accredited investor. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one fie year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid selling commissions to registered broker/dealer and managing dealer for the offering in the amount of $32,500. The Company incurred $36,214 of total expenses associated with this offering, for a net amount of $213,786 and is obligated to issue 93,750 warrants to the registered broker in association with this sale.
On May 15, 2013, the Company entered into an amendment with its investment banking firm to reduce the warrants payable to the firm by 30,000.
On June 12, 2013, the Company conducted a closing under a private placement offering selling 437,500 units for $175,000 to four accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid selling commissions to a registered broker/dealer and managing dealer for the offering in the amount of $22,750. The Company incurred $31,558 of total expenses associated with this offering, for a net amount of $143,442 and is obligated to issue 65,625 warrants to the registered broker in association with this sale.
On June 30, 2013 employees vested 325,700 shares of common stock. The value of the stock was $114,039 and the 325,700 shares were issued in the third quarter of 2013. See Note 15 for further details.
On July 16, 2013, the Company issued a five-year warrant to purchase 22,000 shares of common stock at $0.40 per share for the second month of services under an Investor Relations Letter of Engagement. The warrant was valued at $6,300.
On July 30, 2013, the Company entered into two agreements with independent contractors to deliver a training course for their product. As part of the agreement, the Company issued each contractor 19,445 shares of its common stock, with a value of $7,778 for each of their services, totaling 38,890 shares of its common stock, with a value of $15,556 which was expensed during the third quarter of 2013.
On July 30, 2013, the Company conducted a closing under a private placement offering selling 187,500 units for $75,000 to three accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid a registered broker/dealer and managing dealer for the offering, selling commissions in the amount of $9,750 issued 28,125 warrants to registered broker. Each warrant entitles registered broker, or its assignees, to purchase one share of the Company’s common stock at $0.40 per share for ten years. The Company also incurred $25,659 of expenses associated with this offering, for a net amount of $49,341.
On August 12, 2013, the CEO agreed to convert $35,000 of his notes payable into 100,000 shares of common stock, with a value of $35,000 by exercising his warrants. These shares were issued in the fourth quarter of 2013.
On August 29, 2013, the Company authorized and issued 225,000 shares of common stock with a value of $67,500 to a director and engineer for services performed for the Company.
On August 29, 2013, the Company authorized and issued 17,500 shares of common stock with a value of $6,125 to an employee.
On August 30, 2013 the Company issued 150,000 shares of common stock, valued at $0.25 per share, upon exercise of a warrant form and receipt of $37,500 from a current stockholder.
On August 30, 2013, the Company issued 142,000 shares of common stock, valued at $41,194, for public and investor relation services pursuant to an agreement dated August 26, 2013.
On August 30, 2013, the Company issued a five-year warrant to purchase 22,000 shares of common stock at $0.40 per share for the third and final month of services under an Investor Relations Letter of Engagement. The warrant was valued at $5,311.
On September 23, 2013, the Company issued 31,500 shares of common stock, valued at $11,009 to a consultant for services per a signed contract.
On September 30, 2013, the Company authorized and recognized the expense for the issuance of 150,000 shares of common stock, valued at $66,000 to its CEO pursuant to the terms of his employment agreement. These shares were issued in the first quarter of 2014.
On September 30, 2013, the Company authorized and recognized the expense for the issuance of 104,000 shares of common stock, valued at $45,760 to its Interim CFO pursuant to the terms of her consulting agreement. These shares were issued in the first quarter of 2014.
On September 30, 2013, the Company authorized and recognized the expense for the issuance of 31,500 shares of common stock, valued at $13,388, to a consultant for services per a signed contract.
During the three months ended September 30, 2013, in connection with the issuance of new promissory notes, the Company issued three year warrants for the purchase of 1,023,935 shares of its common stock for $0.40 per share.
On October 1, 2013, the Company sold 250,000 shares of common stock with an aggregate value of $100,000. Each unit sold consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share.
On October 10, 2013, the Company sold 100,000 shares of common stock with an aggregate value of $40,000. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. These shares were issued in the first quarter of 2014.
On October 25, 2013, the Company conducted a closing under a private placement offering selling 787,500 units for $315,000 to eleven accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid a registered broker/dealer and managing dealer for the offering and selling commissions in the amount of $40,950. The Company also incurred $8,774 of expenses associated with this offering, for a net amount of $265,276.
On October 29, 2013, two investors exercised 57,500 warrants to purchase common stock with total cash payments of $14,375.
On November 12, 2013, the Company conducted a closing under a private placement offering selling 1,373,750 units for $549,500 to three accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid a registered broker/dealer and managing dealer for the offering and selling commissions in the amount of $71,435. The Company also incurred $2,314 of expenses associated with this offering, for a net amount of $475,751. These shares were issued in the second quarter of 2014.
On November 20, 2013, the Company conducted a closing under a private placement offering selling 362,500 units for $145,000 to five accredited investors. Each unit consists of one share of common stock, one three year warrant to purchase one share of common stock for $0.55 per share and one five year warrant to purchase one share of common stock for $0.75 per share. In connection with the sale of these units, the Company paid a registered broker/dealer and managing dealer for the offering and selling commissions in the amount of $18,850. The Company also incurred $2,650 of expenses associated with this offering, for a net amount of $123,500.
On November 26, 2013, the Company issued 71,429 shares of common stock, valued at $50,000 for public and investor relation services pursuant to an agreement dated August 26, 2013. These shares were issued in the first quarter of 2014.
On December 31, 2013, the Company authorized 20,000 shares of common stock for engineering assistance with the Company’s security device. The services were valued at $9,165. 15,000 of these shares were issued in the first quarter of 2014. 5,000 shares were owed but not issued as of September 30, 2014
On December 31, 2013, the Company issued 360,000 shares of its common stock to its six directors for director fees. The services were valued at $219,960. These shares were issued in the first quarter of 2014.
On December 31, 2013, the Company issued 100,000 shares of its common stock to its CEO as a bonus for services performed for the Corporation. These shares were valued at $61,100. These shares were issued in the first quarter of 2014.
On December 31, 2013, the Company authorized and recognized the expense for the issuance of 150,000 shares of common stock, valued at $91,650 to its CEO pursuant to the terms of his employment agreement. These shares were issued in the first quarter of 2014.
On December 31, 2013, the Company authorized and recognized the expense for the issuance of 104,000 shares of common stock, valued at $63,544 to its Interim CFO pursuant to the terms of her consulting agreement. These shares were issued in the first quarter of 2014.
On December 31, 2013, the Company authorized and recognized the expense for the issuance of 212,500 shares of common stock, valued at $129,838 to its COO pursuant to the terms of his employment agreement. These shares were issued in the first quarter of 2014.
On December 31, 2013, the Company authorized and recognized the expense for the issuance of 52,800 shares of common stock, valued at $32,261 to its VP of Customer Support pursuant to the terms of his employment agreement. These shares were issued in the first quarter of 2014.
As of December 31, 2013, there were 37,274,292 shares of common stock outstanding, 2,855,979 were owed but not issued and there were no preferred shares.
On February 3, 2014, the Company authorized and recognized the expense for 325,000 shares of common stock, valued at $130,000 to an outside consultant pursuant to an agreement with the consultant. These shares were owed but not issued as of September 30, 2014.
On February 3, 2014, the Company authorized and recognized the expense for 98,039 shares of common stock, valued at $50,000 to an outside consultant pursuant to an agreement with the consultant. These shares were issued in the second quarter of 2014.
On March 31, 2014, the Company authorized and recognized the expense for the issuance of 104,250 shares of common stock, valued at $53,040 to its Interim CFO pursuant to the terms of her consulting agreement. These shares were issued in the second quarter of 2014.
On March 31, 2014, the Company authorized and recognized the expense for the issuance of 150,000 shares of common stock, valued at $76,500 to its CEO pursuant to the terms of his employment agreement. These shares were issued in the second quarter of 2014.
On May 20, 2014, the Company authorized, issued and recognized the expense for 60,000 shares of common stock, valued at $30,600 to a board member.
On June 18, 2014, the Company authorized 200,000 shares of common stock to its interim CFO per the terms of her new employment contract (See Note 15). The associated expense recognized during the second quarter of 2014 was $96,020. These shares were issued in the second quarter of 2014.
On June 30, 2014, the Company authorized and recognized the expense for the issuance of 105,000 shares of common stock, valued at $49,350 to its interim CFO per her new employment contract (See Note 15). These shares were issued in the third quarter of 2014.
On August 1, 2014 the Company authorized and recognized the expense for the issuance of 9,375 shares of common stock, valued at $4,125 to an employee. These shares were owed but not issued as of September 30, 2014.
On September 8, 2014 the Company authorized and recognized the expense for the issuance of 26,230 shares of common stock, valued at $16,000 to a consultant. These shares were owed but not issued as of September 30, 2014.
On September 30, 2014, the Company authorized and recognized the expense for the issuance of 105,000 shares of common stock, valued at $58,800 to its interim CFO per her new employment contract (See Note 15). These shares were owed but not issued as of September 30, 2014.
As of September 30, 2014, there were 40,842,560 common shares issued and outstanding, 470,605 common shares owed but not issued, and no preferred shares issued.
Note 11 - Options and warrants
Options
As of September 30, 2014 and 2013 there are no outstanding options.
Warrants
On January 1, 2013, there were 1,432,500 warrants outstanding.
During the year ended December 31, 2013, 307,500 warrants were exercised at a strike price between $0.25 and $0.40 per warrant.
During the year ended December 31, 2013, the Company issued 10,347,500 warrants to purchase common stock relating to the sale of units as noted in Note 10. All warrants have a term between three and five years and a strike price ranging from $0.55 to $0.75. In connection with the sale of units the Company issued warrants as private placement fees. The number of warrants issued were 744,188 later reduced by 30,000 warrants for a net amount issued of 714,188. These warrants have an exercise price of $.40 per share and have a term of 10 years. Also upon conversion of any of the warrants relating to the sale of the units, the Company is required to issue additional warrants as part of the fee agreement.
In connection with notes payable entered into in 2013, the Company issued 1,123,923 warrants. The value of the warrants was determined using the Black Scholes model with the following weighted average assumptions; Term 3 years, Stock Price at the date of the grant $0.37, Strike Price $0.40, Volatility 121%, Dividend $0, Risk Free Interest Rate 0.32%. The value of $284,914 was recorded as a prepaid loan fee and has been amortized over the life of the loans. As of September 30, 2014 the prepaid loan fee has been fully amortized.
In May of 2013, The Company issued 44,000 warrants for consulting services. The value of the warrants was determined using the Black Scholes. The value of $11,610 was recorded as a prepaid asset and was amortized over the life of the consulting agreement.
In connection with notes payable entered into in the first nine months of 2014, the Company issued 500,000 warrants. The value of the warrants was determined using the Black Scholes. The prepaid loan fee of $154,881 was amortized over the life of the loans. As of September 30, 2014 the prepaid loan fee has been fully amortized.
In connection with the convertible senior secured debentures, the Company issued 7,000,000 warrants during the nine months ended September 30, 2014. The value of the warrants was determined using the Black Scholes. The value of $1,698,766 was recorded as a prepaid loan fee and is being amortized over the life of the loan. As of September 30, 2014, the balance remaining in prepaid loan fees was $1,321,263.
The Company issued 560,000 warrants to the placement agents representing the Company in conjunction with the debenture transaction. The warrants have an exercise price of $0.50, and have a 5 year expiration period. The value of $185,874 was recorded as prepaid loan costs and are being amortized over eighteen months.
A summary of warrants as of September 30, 2014 is as follows:
|
|
Number of Options
|
|
|
Weighted Average
Exercise Price of Options
|
|
|
Number of Warrants
|
|
|
Weighted Average
Exercise Price of Warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 12 - Lease commitments and related party transactions
In December of 2011, the Company leased space in Scottsdale, Arizona for its main headquarters. The lease ran from January 2012 to March 2014 at a rate of $1,907 per month. The lease expired on June 30, 2014. The Company subsequently entered into a new lease on July 1, 2014 (See Note 18).
On July 1, 2014, the Company entered into a forty month office lease agreement ending on October 31, 2017. The lease requires monthly payments of $5,988.
Rent expense for was $12,520 and $18,031 for the nine months ended September 30, 2014 and 2013, respectively.
During the nine months ended September 30, 2014, as part of a new convertible debenture, the Company issued notes payable totaling $295,000 to related parties. The maturity dates for these notes are November 30, 2015. See Note 8 for further details.
See Note 15 for details on stock issued to employees and related party consultants per their employment or consulting contracts with the Company.
Note 13 - Fair Value Measurements
The Company adopted ASC Topic 820-10 to measure the fair value of certain of its financial assets that are required to be measured on a recurring basis. The adoption of ASC Topic 820-10 did not impact the Company’s financial condition or results of operations. ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability. The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:
Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.
Level 2 - Valuations based on quoted prices for similar assets and liabilities in active markets, quoted prices for identical assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
Level 3 - Valuations based on inputs that are supportable by little or no market activity and that are significant to the fair value of the asset or liability. The Company had no level three assets or liabilities as of September 30, 2014 or December 31, 2013; therefore, a reconciliation of the changes during the year is not shown.
The following table presents a reconciliation of all assets and liabilities measured at fair value on a recurring basis as of September 30, 2014:
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Fair Value
|
|
Convertible senior secured debentures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents a reconciliation of all assets and liabilities measured at fair value on a recurring basis as of December 31, 2013:
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 14 - Income Taxes
The Company follows ASC subtopic 740-10 for recording the provision for income taxes. ASC 740-10 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change.
Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse.
The Company’s operations for the nine months ended September 30, 2014 and 2013 resulted in losses, thus no income taxes have been reflected in the accompanying statements of operations.
As of December 31, 2013, the Company had net operating loss carry-forwards that may be used to reduce future income taxes payable. A valuation allowance has been recorded to reduce the net benefit recorded in the financial statements related to this deferred asset. The valuation allowance is deemed necessary as a result of the uncertainty associated with the ultimate realization of these deferred tax assets.
For financial reporting purposes, the Company has incurred a loss since inception to September 30, 2014. Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at September 30, 2014. Further, management does not believe it has taken the position in the deductibility of its expenses that creates a more likely than not potential for future liability under the guidance of FIN 48.
Note 15 - Employment Contracts
During the year ended December 31, 2012, the Company entered into an amended and restated three-year employment contract with its Chief Operating Officer. If the Company meets various goals and criteria during those three years, which have been set forth in the agreement, they will issue a prescribed amount of shares of its common stock to the Chief Operating Officer. The Company reserved 450,000 shares of its common stock as required by the agreement. As of September 30, 2014, in accordance with the terms of the agreement, the employee vested 352,500 shares of restricted stock for achieving milestones as set forth in the employment agreement.
During the year ended December 31, 2012, the Company entered into a three-year contact with its Vice President of Customer Support. If the Company meets various goals and criteria during those three years they will issue a prescribed amount of its common shares to the Vice President of Customer Support, all of which are prescribed in the agreement. The Company reserved 288,000 shares of its common stock as required by the agreement. As of September 30, 2014, in accordance with the terms of the agreement, the employee vested 91,200 shares of restricted stock for achieving milestones as set forth in the employment agreement.
On March 4, 2013, the Company entered into an employment agreement with its CEO/president. The CEO/president has the ability to earn shares of common stock over the term of the agreement. The Company reserved 750,000 shares of its common stock as required by the agreement. Per the agreement, the Company will issue 150,000 common shares on the last day of every fiscal quarter as compensation through that period. As of September 30, 2014, all 750,000 common shares have vested. In addition, the agreement allowed for the Chief Executive Officer and President to earn an initial base salary of $250,000, which began on January 1, 2013.
On March 4, 2013, the Company amended the agreement with its non-employee interim Chief Financial Officer (CFO). The CFO has the ability to earn shares of common stock over the term of the agreement, which ran through March 31, 2014. The Company reserved 416,250 shares of its common stock as required by the agreement. Per the contract, the Company issued a prescribed amount of common shares on the last day of every fiscal quarter, beginning with the second quarter of 2013 and ending on March 31, 2014. As of June 30, 2014, all 416,250 shares vested. In addition, beginning January 1, 2013, the Non-Employee Interim Chief Financial Officer was compensated $3,000 per month.
On May 22, 2014, the Company entered into a second amended agreement with its Non-Employee Interim CFO. The amendment extended the term of the Non-Employee Interim CFO agreement from April 1, 2014 through November 30, 2015. Further, the amendment provides for compensation to the CFO of up to 935,000 shares of the Company’s common stock. As of September 30, 2014, 410,000 shares have vested, leaving 525,000 shares reserved as of September 30, 2014. In addition, the Non-Employee Interim CFO will continue to earn a base monthly retainer of $3,000.
As of September 30, 2014, the Company has a total of 819,300 shares of its common stock reserved for the following employment contracts:
Employee or Position
|
|
Shares
|
|
|
|
|
|
|
Vice President of Customer Support
|
|
|
|
|
|
|
|
|
|
Non-Employee Interim Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
Note 16 - Public and Investor Relations Agreements
On March 1, 2013, the Company entered into a one-year agreement with Kraves PR to assist with public relations as the Company moves into scaled production and distribution. The contract was executed on a project-by-project basis, beginning with media assistance provided at an industry conference in April 2013. All monies paid under this contract were classified in sales, general and administrative expenses as a marketing expenditure.
On August 30, 2013, the Company entered an agreement with an investor relations firm for a period of twelve months, ending May 26, 2014, with the right to cancel services at the end of each subsequent three-month period. The terms of the agreement called for the issuance of 142,000 common shares to be issued for the first three-months of service ending November 26, 2013, and then the equivalent number of shares required to compensate for the $50,000 per period thereafter. In April of 2014, the agreement was terminated.
Note 17 - Interest Expense
The company’s interest expense for the nine months ended September 30, 2014 consisted of the following:
Description
|
|
Amount
|
|
Loan fees
|
|
|
554,936
|
|
Notes payable, related and unrelated
|
|
|
265,848
|
|
Convertible senior secured debentures
|
|
|
377,504
|
|
Bank line of credit
|
|
|
15,244
|
|
Total
|
|
|
1,213,532
|
|
Note 18 - Subsequent events
The Company has evaluated all subsequent events through the date these financial statements were issued and determined that there are no subsequent events to record and the following events to disclose.
On October 8, 2014, 26,667 shares valued at $16,000 became issuable to a consultant. As of the date of this report the shares have not been issued.
On October 29, 2014, a Debenture holder converted $10,000 of the principal amount of their debenture into 20,000 shares of common stock.
On October 29, 2014, a Debenture holder converted $2,500 of the principal amount of their debenture into 5,000 shares of common stock.
On October 31, 2014, a Debenture holder converted $10,000 of the principal amount of their debenture into 20,000 shares of common stock.
On October 31, 2014, a Debenture holder converted $2,500 of the principal amount of their debenture into 5,000 shares of common stock.
On November 6, 2014, a Debenture holder converted $100,000 of the principal amount of their debenture into 200,000 shares of common stock. As of the date of this report the shares have not been issued.
On November 8, 2014, 36,774 shares valued at $16,000 to a consultant became issuable to a consultant. As of the date of this report the shares have not been issued.
On November 13, 2014, 12,000 shares of common stock became issuable to an employee. As of the date of this report the shares have not been issued.
FORWARD-LOOKING STATEMENTS
This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objections of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.
Forward-looking statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words. These forward-looking statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however, consult further disclosures we make in this Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The factors impacting these risks and uncertainties include, but are not limited to:
|
·
|
deterioration in general or global economic, market and political conditions;
|
|
·
|
our ability to diversify our operations;
|
|
·
|
actions and initiatives taken by both current and potential competitors;
|
|
·
|
supply chain disruptions for components used in our product;
|
|
·
|
manufacturers inability to deliver components or products on time;
|
|
·
|
inability to raise additional financing for working capital;
|
|
·
|
the fact that our accounting policies and methods are fundamental to how we report our financial condition and results of operations, and they may require management to make estimates about matters that are inherently uncertain;
|
|
·
|
adverse state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect to existing operations;
|
|
·
|
changes in U.S. GAAP or in the legal, regulatory and legislative environments in the markets in which we operate;
|
|
·
|
our ability to efficiently manage our debt obligations;
|
|
·
|
inability to efficiently manage our operations;
|
|
·
|
inability to achieve future operating results;
|
|
·
|
the unavailability of funds for capital expenditures;
|
|
·
|
our ability to recruit and hire key employees;
|
|
·
|
the inability of management to effectively implement our strategies and business plans; and
|
|
·
|
the other risks and uncertainties detailed in this report.
|
In this form 10-Q references to “Guardian 8”, “G8”, “the Company”, “we,” “us,” “our” and similar terms refer to Guardian 8 Holdings and its wholly owned operating subsidiary, Guardian 8 Corporation.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this report.
Overview
We were incorporated in Nevada on June 8, 2009 as Guardian 6 Corporation. In August of 2009, we changed our name to Guardian 8 Corporation. Our principle offices are located in Scottsdale, Arizona. We were a development stage company from our inception through June 30, 2013, engaged in the design and introduction of a new category of personal security devices, Enhanced Non-Lethal Devices (ENL). Our product, the Pro V2 incorporates a layered defensive approach to help security professionals and consumers protect themselves against personal attacks, while capturing critical images and audio recordings to defend against personal liability.
Effective November 30, 2010 we merged with Global Risk Management & Investigative Solutions (“Global Risk”), a public company, with its common stock registered with the United States Securities and Exchange Commission. We merged into a newly formed wholly owned subsidiary of Global Risk, with Guardian 8 Corporation being the surviving corporation. Post-merger, Global Risk changed its name to Guardian 8 Holdings.
For the nine months ended September 30, 2014 and 2013, the Company was consolidated with its wholly-owned subsidiary, Guardian 8 Corporation. All material intercompany transactions and accounts have been eliminated. Beginning July 1, 2013 as product revenues became sustainable, the Company transitioned from reporting as a development stage Entity to an operating entity. As a result, the financial statements included in this filing have been presented accordingly.
Since inception, our team of engineers and executives has been focused on developing and patenting our first commercial product, (the Guardian 8 Pro V2) as well as the key functions that create market differentiation. We have also been formalizing marketing and manufacturing strategies as well as building customer distribution channels in preparation for our first product launch into the Private Security Market.
During the year ended December 31, 2013, the Company received its first production units assembled by its contract manufacturer and generated initial revenue totaling $43,619.
In 2013, key personnel were hired in the areas of Sales and Operations. These hires include an experienced Vice President of Customer Service, a lead manufacturing engineer, and a Sales Manager. Most sales and marketing staff as well as administrative support staff are in place and will enable us to reach key customers and shorten the sales cycles.
During the first nine months of 2014, the Company expanded its sales team to include regional representatives, as well as non-employee sales and training consultants. These individuals were trained, and are now working to develop relationships with the potential leads identified in the Company’s database.
The Company also added William Clough to its Board of Directors, effective April 9, 2014.
The Company also initiated development efforts on the new consumer product, which is targeted for release in 2015. During the first nine months of 2014, the Company expensed $234,758 for these development efforts.
Critical Accounting Policies
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. In consultation with our Board of Directors, we have identified several accounting principles that we believe are key to the understanding of our financial statements. These important accounting policies require management’s most difficult, subjective judgments.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Net Loss Per Share
We adopted ASC 260, “Earnings Per Share” that requires the reporting of both basic and diluted earnings (loss) per share. Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In accordance with ASC 260, any anti-dilutive effects on net income (loss) per share are excluded.
Going Concern
Our financial statements are prepared using generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Our ability to continue as a going concern is dependent upon our ability to locate sources of capital, and attain future profitable operations. Our management is currently initiating their business plan. The accompanying financial statements do not include any adjustments that might be necessary should we be unable to continue as a going concern.
Revenue Recognition
It is the Company’s policy that revenues are recognized in accordance with ASC 605-10, “Revenue Recognition”. The company therefore recognizes revenue from sales of product upon delivery to its customers where the amount is fixed or determinable, and collectability is probable. Cash payments received in advance are recorded as deferred revenue. Extended warranties are recorded as deferred revenue and amortized according to the number of months included in service. The Company recognized $39,346 and $25,651 in revenues for the nine months ended September 30, 2014 and 2013, respectively.
Fair Value of Financial Instruments
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2014 and December 31, 2013. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, accounts receivable, accounts payable and amounts due to related party. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.
Income Taxes
The Company follows ASC subtopic 740-10, “Accounting for Income Taxes” for recording the provision for income taxes. ASC 740-10 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change.
Principles of consolidation
For the nine months ended September 30, 2014 and 2013, the Company was consolidated with its wholly-owned subsidiary, Guardian 8 Corporation. All material intercompany transactions and accounts have been eliminated.
Cash and cash equivalents
Cash and cash equivalents include all cash balances in non-interest bearing accounts and money-market accounts. The Company places its temporary cash investments with quality financial institutions. At times such investments may be in excess of Federal Deposit Insurance Corporation (FDIC) insurance limit. The Company does not believe it is exposed to any significant credit risk on cash and cash equivalents. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. As of September 30, 2014 and December 31, 2013, there were cash equivalents of $1,854,092 and $305,649 respectively.
Inventory
During the nine months ended September 30, 2014, the Company accepted the delivery of 6,851 units of its ProV2 from its contract manufacturer. These deliveries were part of the Company’s initial low rate production and in addition to the follow-on order of 10,000 production units. The purchase terms require 50% prepayment at the time of order, and the remaining 50% to be paid prior to shipment to the United States. As of September 30, 2014, the Company had prepaid its contract manufacturer approximately $406,998 toward units in transit and in production for delivery prior to December 31, 2014. This prepayment is partial or full payment on 4,848 units, 2,040 of which were received on October 1, 2014. We believe this inventory will be adequate to fulfill orders for the next twelve months.
Research and development costs
The Company expenses all costs of research and development as incurred. There are research and development costs included in other general and administrative expenses of $244,794 and $543,779 for the nine months ended September 30, 2014 and 2013 respectively. The Company intends to continue investing in the development of future products, including a new consumer product anticipated for market launch in 2015.
Property and equipment
Property and equipment are stated at cost. Major improvements are charged to the asset accounts while replacements, maintenance and repairs which do not improve or extend the lives of respective assets are expensed.
The Company depreciates its property and equipment for the financial reporting purposes using the straight-line method based on the following useful lives of the assets:
Equipment
|
2-5 years
|
Tooling
|
10 years
|
Computer equipment
|
3 years
|
Leasehold improvements
|
Life of lease
|
Furniture and fixtures
|
5 years
|
Warehouse equipment
|
5 years
|
Recent Developments
On January 17, 2014, the Company entered into a revolving line of credit agreement with Cornerstone Bank, N.A. The agreement provided for an aggregate of up to $700,000 (which was subsequently increased to $900,000 in April of 2014) at any time outstanding pursuant to a revolving line of credit and was to mature on January 16, 2015. The agreement was secured by inventory, work in process, accounts receivable, letter of credit, and was personally guaranteed by the Company’s Chief Executive Officer/President. Borrowings carried an interest rate of 6% per annum, with monthly interest payments to be paid by the Company. The line of credit was fully paid as of September 30, 2014.
As part of the agreement, the Company entered into a Letter of Credit Rights Control Agreement with F&M Bank & Trust Company. Per this agreement, if the Company defaulted on the line of credit, F&M Bank & Trust Company would then be held liable to Cornerstone Bank, N.A. for the payment of the line of credit. In addition, the Company would then owe the amount to F&M Bank & Trust Company. This agreement ceased with the satisfactory payment of the debt outstanding.
During the three months ended March 31, 2014, the Company received three notes payable from related parties in the amount of $475,000, and one note payable from an unrelated party in the amount of $25,000. All of the notes were unsecured, bearing interest at 12% per annum, and were due on July 15, 2014. These notes also included a three-year warrant for each of $1.00 of principal included in the note. All of the notes and related accrued interest had been paid in full as of September 30, 2014.
During the nine months ended September 30, 2014, the Company issued 159,375 shares of its common stock, with an aggregate value of $80,625 for compensation. The Company also issued 1,023,519 shares of its common stock with an aggregate value of $483,810 for services.
During the nine months ended September 30, 2014, the Company issued $7,000,000 of convertible senior secured debentures. These debentures are due on November 30, 2015, bear interest at a rate of 8%, and include one five-year warrant, with a strike price of $0.60 per share, for each dollar issued.
As part of issuing these debentures, the company incurred loan costs of $809,939. The loan costs are being amortized over an 18-month period ending November 30, 2015.
The Company issued the following convertible Senior Secured Debentures:
|
|
|
|
1st Closing
|
|
|
2nd Closing
|
|
|
|
|
|
|
|
|
|
|
1. |
|
Date of issuance
|
|
May 27, 2014
|
|
|
June 2, 2014
|
|
|
|
|
|
|
|
|
|
|
2. |
|
Gross amount of debentures
|
|
$ |
5,250,000 |
|
|
$ |
1,750,000 |
|
|
|
|
|
|
|
|
|
|
|
|
3. |
|
Net cash received:
|
|
|
|
|
|
|
|
|
|
|
Gross amount of debentures
|
|
$ |
5,250,000 |
|
|
$ |
1,750,000 |
|
|
|
Less
|
|
|
|
|
|
|
|
|
|
|
Repay bank loan and interest
|
|
|
(901,510 |
) |
|
|
- |
|
|
|
Conversion of short-term debt
|
|
|
0 |
|
|
|
(195,000 |
) |
|
|
Commissions and fees
|
|
|
(439,979 |
) |
|
|
(113,715 |
) |
|
|
Attorney fees
|
|
|
(55,000 |
) |
|
|
(5,370 |
) |
|
|
Other fees
|
|
|
(5,000 |
) |
|
|
(5,000 |
) |
|
|
Amount held in escrow by 3rd party
|
|
|
(7,000 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash received
|
|
$ |
3,841,511 |
|
|
$ |
1,430,915 |
|
|
|
|
|
|
|
|
|
|
|
|
4.
|
|
Term
|
|
18 Months
Due November 30, 2015
|
|
|
18 Months
Due November 30, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
5. |
|
Interest rate
|
|
8% from May 27, 2014
|
|
|
8% from June 2, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
6.
|
|
Interest payment dates
|
|
Quarterly
Beginning May 1, 2015
|
|
|
Quarterly
Beginning May 1, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7. |
|
Warrants to debenture holders:
|
|
1st Closing |
|
|
2nd Closing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number issued
|
|
|
5,250,000 |
|
|
|
1,750,000 |
|
|
|
Price per share
|
|
$ |
0.60 |
|
|
$ |
0.60 |
|
|
|
Term
|
|
5 years
|
|
|
5 years
|
|
|
|
See condition number 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8. |
|
Warrants to placement agents
|
|
|
|
|
|
|
|
|
|
|
Number issued
|
|
|
420,000 |
|
|
|
140,000 |
|
|
|
Price per share
|
|
$ |
0.50 |
|
|
$ |
0.50 |
|
|
|
Term
|
|
5 years
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
9. |
|
Number of accredited investors
|
|
|
10 |
|
|
|
17 |
|
The following conditions/terms apply to both closings:
1. Use of funds
The funds will be used for:
Repay short-term debt
Repay bank line of credit and interest
Sales and marketing expenses
Purchase additional inventory
International sales channel development
Research and development of a consumer ENL device
Purchase of fixed assets
General corporate purposes
2. Conversion Rights
The debentures may be converted by each buyer commencing on the 91st day following closing and through maturity, either in whole or in part, up to the full principal amount and accrued interest thereunder into shares of common stock at $0.50 per share.
The Company may force conversion of the debentures into shares of common stock at $0.50 per share, either in whole or in part, if the closing sale price of shares of common stock during any ten consecutive trading days has been at or above $1.00 per share.
In the event the average closing price of the common stock for the ten trading days immediately preceding, but not including, the maturity date of the debentures is equal to or greater than $0.80, then on the maturity date, the buyers must convert all remaining principal due under the debentures.
The debentures contain provisions limiting the conversion to the extent that, as a result of such conversion, each buyer would beneficially own more than 4.99% (subject to waiver) in the aggregate of the issued and outstanding shares of the company’s common stock, calculated immediately after giving effect to the issuance of shares of common stock upon conversion of the debentures.
In addition, upon conversion of the debentures, the number of Class C warrants issued to each buyer shall automatically double.
Right to Redeem Debenture. Beginning on the 91st day following the closing and so long as a registration statement covering all the registerable securities is effective, the company has the option of redeeming the principal, in whole or in part by paying the amount equal to 100% of the principal, together with accrued and unpaid interest by giving ten business days prior notice of redemption to the buyers.
Security of Debentures. The debentures are guaranteed, pursuant to “Secured Guaranty” and “Pledge and Security Agreement by Guardian 8 Corporation and secured interest in all of the assets of the company and Guardian 8 Corporation.
Registration Rights. The Company has agreed to file a “resale” registration statement with the Securities and Exchange Commission covering all shares of common stock underlying the debentures and Class C warrants within 90 days of the final closing, on or before August 31, 2014, and to maintain the effectiveness of the registration statement for five years, or until all securities have been sold or are otherwise able to be sold pursuant to Rule 144. The Registrant has agreed to use its reasonable best efforts to have the registration statement declared effective within 120 days of the filing date. The Company is obligated to pay to investors liquidated damages equal to 1.0% per month in cash for every thirty day period up to a maximum of six percent, (i) that the registration statement has not been filed after the filing date, (ii) following the effectiveness date that the registration statement has not been declared effective; and (iii) as otherwise set forth in the financing agreements. On October 29, 2014 the Company’s registration was declared effective.
3. Events of Default.
·
|
Failure of Registrant to timely file the registration statements and have same declared effectively by the SEC within the time periods set forth in the Agreement;
|
·
|
The suspension of the company’s common stock from the OTC:QB for five consecutive days or for more than an aggregate of ten days in 365 days;
|
·
|
Failure to pay principal and interest when due;
|
·
|
An uncured breach of any material covenant, term or condition in any of the Debentures or related agreements;
|
·
|
A breach of any material representation or warranty made in any of the Debentures or related agreements: and
|
·
|
Any form of bankruptcy or insolvency proceeding is instituted against the companies.
|
4. Valuation of Warrants
The warrants issued with the debentures were valued using the Black-Scholes option pricing model and bifurcated out of the note proceeds and recorded as additional paid in capital in the amounts of $1,274,075 for the first closing and $424,691 for the second closing. A discount on the debenture was recorded in the same amount and is being amortized into interest expense over the eighteen month life of the debenture using the interest method.
As of September 30, 2014, $377,504 was amortized into expense and the remaining discounts were $1,321,262.
5. Debenture balances as of September 30, 2014
|
|
1st Closing
|
|
|
2nd Closing
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
Gross debentures
|
|
$ |
5,250,000 |
|
|
$ |
1,750,000 |
|
|
$ |
7,000,000 |
|
Less discount
|
|
|
990,947 |
|
|
|
330,315 |
|
|
|
1,321,262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Debentures
|
|
$ |
4,259,053 |
|
|
$ |
1,419,685 |
|
|
$ |
5,678,738 |
|
During the nine months ended September 30, 2014, the Company issued 159,375 shares of its common stock, with an aggregate value of $80,625 for compensation. The Company also issued 1,023,519 shares of its common stock, with an aggregate value of $483,812 for services.
Effective November 1, 2014, we hired Gary Kuty as Vice President of Sales for Guardian 8 Corporation. Kuty founded Kuty & Associates, LLC and oversaw its consulting and training operations in Dayton and Las Vegas for over a decade and became a well-respected author on corporate security matters. As a 40 year veteran of the police and security industries, he is a well-known confidant to security company leaders throughout the U.S. As part of his hiring, Guardian 8 Corporation entered into an employment agreement with Mr. Kuty, which is described in Item 5 below.
Results of Operations for Guardian 8 Corporation for the nine months ended September 30, 2014 and 2013.
|
|
Nine Months Ended September 30, 2014
|
|
|
Nine Months Ended September 30, 2013
|
|
|
Increase/ (Decrease)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) from operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
During the nine months ended September 30, 2014 and 2013, we had revenues of $39,346 and $25,651, and corresponding costs of sales of $27,501 and $6,696, respectively associated with shipments of our commercial products.
We generated net losses of $4,241,082 and $2,160,338 for the nine months ended September 30, 2014 and 2013, respectively. Our losses for these periods included research and development costs related to our ProV2 and new consumer device of $244,794 and $543,779, as well as general and administrative expenses of $2,728,599 and $1,561,614 for the same nine month periods.
We anticipate continued losses from operations until such time as we generate sufficient revenues through the sale of our device to cover both our cost of manufacturing, and sales, general and administrative expenditures.
Satisfaction of our cash obligations for the next 12 months.
Since inception, we have financed cash flow requirements through the issuance of common stock for cash and services, as well as both convertible and non-convertible term notes, and bank financing. As of September 30, 2014, our cash balance was $1,854,092. Our plan for satisfying our cash requirements for the next twelve months is through the funds from additional offerings of our common stock, third party financings, and revenue generated through the sales of our products and training services. We may not generate sufficient amounts of revenues to meet our working capital requirements. Consequently, we intend to make appropriate plans to ensure sources of additional capital in the future to fund growth and expansion through additional equity or debt financing or credit facilities.
As we continue to expand operational activities, we may continue to experience net negative cash flows from operations, pending receipt of revenues from our product sales, and will be required to obtain additional financing to fund operations through common stock offerings and debt borrowings, giving consideration to loans and working diligently to move sales ahead to the extent necessary to provide working capital.
We anticipate incurring operating losses over the next twelve months as we expand distribution, and invest in the development of our new consumer product. Our brief operating history makes predictions of future operating results difficult to ascertain. Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies seeking to establish cash flows sufficient to satisfy their operating needs. Such risks include, but are not limited to, an evolving and unpredictable business model and the management of growth. To address these risks we must, among other things, implement and successfully execute our business and marketing strategy, continue to develop and upgrade technology and products, respond to competitive developments, and continue to attract, retain and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.
As a result of our cash requirements and our lack of significant revenues, we anticipate continuing to issue common stock in exchange for loans and/or equity financing, which may have a substantial dilutive impact on our existing stockholders.
Summary of any product research and development that we will perform for the term of our plan of operation.
We expense all costs of research and development as incurred. There are research and development costs included in other general and administrative expenses of $244,794 and $543,779 for the nine months ended September 30, 2014 and 2013, respectively, which included approximately $234,758 toward our new consumer device. We anticipate expending up to $500,000 on additional significant product research and development for our consumer device, the next program pending on our product road map.
In addition to investments in research and development expenditures, we have also retained the services of a patent attorney to assist us with the filing and protection of key utility applications, as well as future technologies to be incorporated in next generation products for the commercial security and consumer markets. Costs associated with the filing of intellectual property has been capitalized and will be amortized over the 20-year life of the patents when issued.
Changes in the number of employees.
We have ten full-time employees, C. Stephen Cochennet, Chief Executive Officer, Paul Hughes, Chief Operations Officer, Jose Rojas, Vice President of Customer Support, our lead manufacturing engineer, five regional sales managers, a customer service representative, and one administrative support person for Guardian 8 Corporation. We utilize the services of several contract personnel, engineers and other professionals on an as needed basis. We are currently managed by C. Stephen Cochennet, Kathleen Hanrahan and Paul Hughes with the assistance of our board of directors. We look to Mr. Cochennet, Ms. Hanrahan and Mr. Hughes for entrepreneurial, organizational and management skills. We plan to continue to use consultants, legal and patent attorneys, design and mechanical engineers, engineers and accountants as necessary. We intend to continue hiring sales and operations employees in 2015 to facilitate go to market activities. A portion of any employee compensation likely would include direct stock grants, or the right to acquire common stock in the company, which would dilute the ownership interest of holders of existing shares of our common stock.
Expected purchase or sale of plant and significant equipment.
We anticipate investing significant resources in the purchase of a facility and equipment in the near future; as we will begin to scale distribution operations throughout 2014 and 2015.
Liquidity and Capital Resources
Working capital is summarized and compared as follows:
|
|
September 30, 2014
|
|
|
December 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital / (deficit)
|
|
|
|
|
|
|
|
|
Changes in cash flows are summarized as follows:
We had a net loss of $4,241,082 for the nine months ended September 30, 2014. This loss was offset by non-cash items such as stock issued for services of $483,812, stock issued for compensation of $80,625, depreciation and amortization of $68,001, the amortization of discount on notes payable of $154,881, the amortization of discount on convertible debentures of $377,503, and the allowance for bad debts of $4,978. We had cash used by the increase in accounts receivable of $8,175, increase in prepaid loan costs of $303,949, increase of inventory of $1,177,463, increase in rent and security deposits of $11,180, and the decrease in accounts payable and accrued expenses of $39,382. We had cash provided due to the decrease in prepaid expenses of $149,549, decrease in deposits on inventory of $89,984, increase in deferred revenue of $1,175 and increase in accrued interest of $148,855.
We had cash used by investing activities of $105,756 for the purchase of property and equipment for the nine months ended September 30, 2014.
We had cash provided by financing activities of $5,876,067 for the nine months ended September 30, 2014. This included proceeds from notes payable to related parties of $475,000 proceeds from notes payable to unrelated parties of $25,000, proceeds from a line of credit with a bank of $900,000, and proceeds from the issuance of convertible senior secured debentures of $7,000,000. These were offset by a repayment of notes payable to related parties of $1,498,933, repayment of notes payable to unrelated parties of $125,000, and the repayment of a line of credit with a bank of $900,000.
We had a net loss of $2,160,338 for the nine months ended September 30, 2013. This included non-cash items such as stock issued or services of $216,147, stock issued for compensation of $323,344, depreciation and amortization of $33,842, amortization of discount on notes payable of $26,636, and the allowance for bad debts of $952. We had cash used by an increase in accounts receivable of $12,987, increase in prepaid expenses of $30,804, an increase in deposits on inventory of $89,478 and an increase in inventory of $65,974. We had cash provided due to the increase in accounts payable and accrued expenses of $245,845, an increase in deferred revenue of $1,050, an increase in accrued interest of $8,162 and an increase in insurance payable of $64,374.
We had cash used by investing activities of $165,221 for the nine months ended September 30, 2013, due to the purchase of property and equipment, and the Company’s website.
We had cash provided by financing activities of $1,765,556 for the nine months ended September 30, 2013. This included proceeds from the sale of common stock of $806,623, proceeds from notes payable to related parties of $858,933, and proceeds from notes payable to unrelated parties of $100,000.
As we expand our activities, we may, and most likely will, continue to experience net negative cash flows from operations, pending receipt of revenues from product sales. Additionally we anticipate obtaining additional financing to fund operations through common stock offerings, repay the current debt obligations associated with the unconverted debentures, and to the extent available, obtain additional financing through either convertible or non-convertible notes payable, necessary to augment our working capital. We are also evaluating additional sources of inventory financing that may be available once orders for our product are received.
We anticipate that we will incur operating losses in the next twelve months. Our brief operating history makes predictions of future operating results difficult to ascertain.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
Not applicable.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer, C. Stephen Cochennet and Kathleen Hanrahan, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Report. Based on the evaluation, Mr. Cochennet and Ms. Hanrahan concluded that our disclosure controls and procedures are effective in timely alerting them to material information relating to us (including our consolidated subsidiaries) required to be included in our periodic SEC filings.
Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal controls over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
Internal control systems, no matter how well designed and operated, have inherent limitations. Therefore, even a system which is determined to be effective cannot provide absolute assurance that all control issues have been detected or prevented. Our systems of internal controls are designed to provide reasonable assurance with respect to financial statement preparation and presentation.
PART II--OTHER INFORMATION
We may become involved in various routine legal proceedings incidental to our business. However, to our knowledge as of the date of this report, there are no material pending legal proceedings to which we are a party or to which any of our property is subject.
Our significant business risks are described in Item 1A to Form 10-K for the year ended December 31, 2013 to which reference is made herein.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On June 30, 2014, 105,000 shares of common stock vested pursuant to the terms of the agreement with our Interim CFO (Kathleen Hanrahan). These shares were issued in August of 2014.
On August 1, 2014, 9,375 shares of common stock became issuable to an employee. As of the date of this report the shares have not been issued.
On September 8, 2014, 26,230 shares valued at $16,000 to a consultant became issuable to a consultant. As of the date of this report the shares have not been issued.
On September 30, 2014, 105,000 shares of common stock vested pursuant to the terms of the agreement with our Interim CFO (Kathleen Hanrahan). As of the date of this report the shares have not been issued.
Subsequent Issuances After Quarter-End
On October 8, 2014, 26,667 shares valued at $16,000 became issuable to a consultant. As of the date of this report the shares have not been issued.
On November 6, 2014, in connection with the conversion of a $100,000 Debenture by Wolverine Flagship Fund Trading Limited, we authorized the issuance of 7,145 restricted shares of common stock for interest associated with the principal amount of the debenture being converted.
On November 8, 2014, 36,774 shares valued at $16,000 to a consultant became issuable to a consultant. As of the date of this report the shares have not been issued.
On November 13, 2014, 12,000 shares of common stock became issuable to an employee. As of the date of this report the shares have not been issued.
All of the above-described issuances were exempt from registration pursuant to Section 4(a)(2) and/or Regulation D of the Securities Act as transactions not involving a public offering. With respect to each transaction listed above, no general solicitation was made by either the Company or any person acting on its behalf. All such securities issued pursuant to such exemptions are restricted securities as defined in Rule 144(a)(3) promulgated under the Securities Act, appropriate legends have been placed on the documents evidencing the securities, and may not be offered or sold absent registration or pursuant to an exemption therefrom.
Issuer Purchases of Equity Securities
We did not repurchase any of our equity securities during the quarter ended September 30, 2014.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
None.
Employment Agreement
Kuty Executive Employment Agreement
Effective November 1, 2014, G8 entered into an employment agreement with Gary Kuty to act as G8’s Vice President of Sales. Mr. Kuty’s employment agreement was approved by the board of directors of G8 and the Registrant.
In general, Mr. Kuty’s employment agreement contains provisions concerning terms of employment, voluntary and involuntary termination, indemnification, severance payments, and other termination benefits, in addition to a non-compete clause and certain other perquisites, such as; long-term disability insurance.
The original term of Mr. Kuty’s employment agreement runs from November 1, 2014 until October 31, 2014.
Mr. Kuty’s employment agreement provides for an initial annual base salary of $140,000, which may be adjusted by the board of directors of G8.
In addition, Mr. Kuty is eligible to receive annual short term incentive bonuses as determined by a review at the discretion of the G8 board of directors. Further, Mr. Kuty shall be eligible to be issued 200,000 restricted shares of the Registrant’s common stock, which will vest on October 31, 2017 assuming Kuty remains employed with G8 through such date subject to earlier vesting as set forth in the employment agreement. Further, we granted Mr. Kuty the opportunity to receive up to 420,000 shares of the Registrant’s common stock under the employment agreement. Up to 23,333 shares shall be eligible to be issued on December 31, 2014 upon successful completion of pre-determined objectives detailed by G8’s CEO and/or Board of Directors and in accordance with the employment agreement. In addition, up to 140,000 shares shall be eligible to be issued on December 31, 2015 upon successful completion of pre-determined objectives detailed by G8’s CEO and/or Board of Directors and in accordance with the employment agreement. Further, up to 140,000 shares shall be eligible to be issued on December 31, 2016 upon successful completion of pre-determined objectives detailed by G8’s CEO and/or Board of Directors and in accordance with the employment agreement and the remaining 140,000 shares shall be eligible to be issued on October 31, 2017 upon successful completion of pre-determined objectives detailed by G8’s CEO and/or Board of Directors.
In the event of a termination of employment with G8 by G8 without “cause” or Kuty for “good reason” (as defined in the employment agreement), Mr. Kuty would receive: (i) a lump sum payment equal to all earned but unpaid base salary through the date of termination of employment or death; (ii) a lump sum payment equal to a pro rata portion of any bonus or incentive payment to which he would have been entitled had he remained continuously employed for the full fiscal year in which death, disability or termination occurred and continued to perform his duties in the same manner as they were performed immediately prior to the death, disability or termination; (iii) 6-months base salary, payable in accordance with the Registrant’s ordinary payroll practices; and (iv) immediate vesting of all equity awards (including but not limited to stock options and restricted shares).
In the event of a termination of employment with G8 by G8 by reason of incapacity, disability or death, Mr. Kuty, or his estate, would receive: (i) a lump sum payment equal to all earned but unpaid base salary through the date of termination of employment or death; (ii) a lump sum payment equal to a pro rata portion of any bonus or incentive payment to which he would have been entitled had he remained continuously employed for the full fiscal year in which death, disability or termination occurred and continued to perform his duties in the same manner as they were performed immediately prior to the death, disability or termination; (iii) payment of his base salary equal to one month for each two months Rojas was employed under the terms of the employment agreement, with a maximum payment of six months of base salary; and (iv) immediate vesting of all equity awards (including but not limited to stock options and restricted shares).
In the event of a termination of Mr. Kuty’s employment with G8 by reason of change in control or business combination (as defined in the employment agreement), Mr. Kuty, would receive: (i) a lump sum payment equal to all earned but unpaid base salary through the date of termination of employment; (ii) a lump sum payment equal to a pro rata portion of any bonus or incentive payment to which he would have been entitled had he remained continuously employed for the full fiscal year in which death, disability or termination occurred and continued to perform his duties in the same manner as they were performed immediately prior to the death, disability or termination; (iii) during such unexpired term of the employment agreement, or for 6-months thereafter, whichever is shorter, he shall continue to receive on a semimonthly basis, his base salary then in effect upon the date of such change in control notice; and (iv) and immediate vesting of all equity awards (including but not limited to stock options and restricted shares).
If the event of a termination of Mr. Kuty’s employment by G8 for “cause” (as defined in the employment agreement), Mr. Kuty would receive all earned but unpaid base salary through the date of termination of employment.
The above description of Mr. Kuty’s employment agreement is qualified in its entirety by reference to the full text of that agreement, a copy of which is attached hereto as Exhibit 10.86.
Gary H. Kuty is the new Vice President of Sales for Guardian 8 Corporation. Gary is a forty year veteran of the law enforcement and private security profession. Gary is a graduate of Youngstown State University, Youngstown, Ohio with a Bachelor of Science in Law Enforcement Administration, and a minor in marketing. Gary has worked in a variety of positions, from managing security business operations on the west coast and Midwest to overseeing the sales and operations of a fifty million dollar regional security and alarm company in the Midwest. For the past twelve years Gary has served as the President & CEO of Kuty and Associates, LLC, a professional security consulting agency based in Dayton, Ohio, with a branch office in Las Vegas. The company has built a client base includes international to startup companies. He is Past President and Chairman of both the Ohio Association of Security and Investigation Services (OASIS) and the National Council of Investigation and Security Services (NCISS). Gary was also appointed to serve on the Security Services Council for the American Society of Industrial Security (ASIS) where for the past two years he served as Council Vice Chair and is a former Chair. Gary also currently serves as Managing Director for the National Security Alliance. Gary has had numerous security and sales related articles published in several trade association journals and has lectured on a variety of sales and marketing topics to several professional security organizations.
Press Releases
On August 27, 2014, we issued a press release disclosing Anderson Security Agency winning a new account incorporating our ENL device. A copy of the press release is attached hereto as Exhibit 99.27.
On September 16, 2014, we issued a press release disclosing Securatex winning a new account incorporating our ENL device. A copy of the press release is attached hereto as Exhibit 99.28.
On September 18, 2014, we issued a press release disclosing the hiring of Lex Hemeyer as director of International Sales. A copy of the press release is attached hereto as Exhibit 99.29.
On September 29, 2014, we issued a press release disclosing the receipt of the Campus Safety BEST Award. A copy of the press release is attached hereto as Exhibit 99.30.
On November 3, 2014, we issued a press release disclosing the hiring of Gary Kuty as our Vice President of Sales. A copy of the press release is attached hereto as Exhibit 99.31.
Debenture Conversions
On October 30, 2014, a Debenture holder (Cranshire Capital Master Fund) converted $10,000 of the principal amount of their debenture into 20,000 shares of common stock.
On October 30, 2014, a Debenture holder (Equitec Specialists) converted $2,500 of the principal amount of their debenture into 5,000 shares of common stock.
On October 31, 2014, a Debenture holder (Cranshire Capital Master Fund) converted $10,000 of the principal amount of their debenture into 20,000 shares of common stock.
On October 31, 2014, a Debenture holder (Equitec Specialists) converted $2,500 of the principal amount of their debenture into 5,000 shares of common stock.
On November 6, 2014, a Debenture holder (Wolverine Flagship Fund Trading Limited) converted $100,000 of the principal amount of their debenture into 200,000 shares of common stock.
All of the shares issued upon conversion of the debentures were registered and freely tradable pursuant to the Form S-1 registration statement declared effective by the United States Securities and Exchange Commission on October 29, 2014. Further, with each conversion, the Class C Warrant held by each debenture holder automatically increased by the amount of shares of common stock issued upon each conversion. As a result of the above conversions, an additional 250,000 Class C warrants are now outstanding.
Exhibit No.
|
|
Description
|
2.1
|
|
Agreement and Plan of Merger among Global Risk Management & Investigative Solutions, G8 Acquisition Subsidiary, Inc. and Guardian 8 Corporation effective November 30, 2010 (incorporated by reference to Exhibit 2.1 to the Form 10-Q filed on August 6, 2010)
|
2.2
|
|
Articles of Merger (incorporated by reference to Exhibit 2.1 to the Form 8-K filed on December 21, 2010)
|
3.1
|
|
Amended and Restated Articles of Incorporation, as currently in effect (incorporated by reference to Exhibit 3.1 to Form 10-K filed on March 23, 2011)
|
3.2
|
|
Bylaws, as currently in effect (incorporated by reference to Exhibit 3.1(ii) to Form 8-K filed on April 30, 2012)
|
3.3
|
|
Certificate of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Form 8-K filed on December 21, 2010)
|
4.1
|
|
Article VI of Amended and Restated Articles of Incorporation (included in Exhibit 3.1)
|
4.2
|
|
Article II and Article VIII of Bylaws (incorporated by reference to Exhibit 3(ii)(a) to Form S-1 filed on May 16, 2008)
|
10.1
|
|
Convertible Term Note and Warrant issued to C. Stephen Cochennet dated October 13, 2011 (incorporated by reference to Exhibit 10.1 to the Form 10-Q filed on November 14, 2011)
|
10.2†
|
|
Hughes Employment Agreement effective December 1, 2011 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on December 9, 2011)
|
10.3†
|
|
Hanrahan Engagement Agreement effective April 30, 2012 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on April 30, 2012)
|
10.4
|
|
$100,000 Term Note issued to C. Stephen Cochennet dated November 13, 2012 (incorporated by reference to Exhibit 10.4 to the Form 10-Q filed on November 19, 2012)
|
10.5
|
|
$50,000 Term Note issued to C. Stephen Cochennet dated December 10, 2012 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on January 8, 2013)
|
10.6
|
|
$50,000 Term Note issued to C. Stephen Cochennet dated December 28, 2012 (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on January 8, 2013)
|
10.7
|
|
$50,000 Term Note issued to C. Stephen Cochennet dated January 24, 2013 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on January 31, 2013)
|
10.8
|
|
$100,000 Term Note issued to C. Stephen Cochennet dated March 6, 2013 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on March 18, 2013)
|
10.9
|
|
$50,000 Term Note issued to James G. Miller dated March 6, 2013 (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on March 18, 2013)
|
10.10 †
|
|
Cochennet Employment Agreement dated March 4, 2013 (incorporated by reference to Exhibit 10.3 to the Form 8-K filed on March 18, 2013)
|
10.11 †
|
|
Hanrahan Amendment No. 1 to Interim CFO Agreement dated March 4, 2013 (incorporated by reference to Exhibit 10.4 to the Form 8-K filed on March 18, 2013)
|
10.12 †
|
|
Hughes Amended and Restated Employment Agreement with Guardian 8 Corporation effective October 1, 2012 (incorporated by reference to Exhibit 10.5 to the Form 8-K filed on March 18, 2013)
|
10.13 †
|
|
Rojas Employment Agreement with Guardian 8 Corporation effective October 1, 2012 (incorporated by reference to Exhibit 10.6 to the Form 8-K filed on March 18, 2013)
|
10.14 †
|
|
Silva Employment Agreement with Guardian 8 Corporation effective March 11, 2013 (incorporated by reference to Exhibit 10.7 to the Form 8-K filed on March 18, 2013)
|
10.15
|
|
$50,000 Term Note issued to Corey Lambrecht dated March 26, 2013 (incorporated by reference to Exhibit 10.15 to the Form 10-Q filed on May 15, 2013)
|
10.16
|
|
Extension No. 1 to $100,000 Term Note issued to C. Stephen Cochennet dated November 13, 2012 (incorporated by reference to Exhibit 10.16 to the Form 10-Q filed on May 15, 2013)
|
10.17
|
|
Extension No. 2 to $100,000 Term Note issued to C. Stephen Cochennet dated November 13, 2012 (incorporated by reference to Exhibit 10.17 to the Form 10-Q filed on May 15, 2013)
|
10.18
|
|
Extension No. 1 to $50,000 Term Note issued to C. Stephen Cochennet dated December 10, 2012 (incorporated by reference to Exhibit 10.18 to the Form 10-Q filed on May 15, 2013)
|
10.19
|
|
Extension No. 2 to $50,000 Term Note issued to C. Stephen Cochennet dated December 10, 2012(incorporated by reference to Exhibit 10.19 to the Form 10-Q filed on May 15, 2013)
|
10.20
|
|
Extension No. 1 to $50,000 Term Note issued to C. Stephen Cochennet dated December 28, 2012 (incorporated by reference to Exhibit 10.20 to the Form 10-Q filed on May 15, 2013)
|
10.21
|
|
Extension No. 1 to $50,000 Term Note issued to C. Stephen Cochennet dated January 24, 2013 (incorporated by reference to Exhibit 10.21 to the Form 10-Q filed on May 15, 2013)
|
10.22
|
|
Extension No. 2 to $50,000 Term Note issued to C. Stephen Cochennet dated May 27, 2013 (incorporated by reference to Exhibit 10.22 to the Form 10-Q filed on August 14, 2013)
|
10.23
|
|
Extension No. 1 to $50,000 Term Note issued to James Miller dated June 4, 2013 (incorporated by reference to Exhibit 10.23 to the Form 10-Q filed on August 14, 2013)
|
10.24
|
|
Extension No. 1 to $100,000 Term Note issued to C. Stephen Cochennet dated June 4, 2013 (incorporated by reference to Exhibit 10.24 to the Form 10-Q filed on August 14, 2013)
|
10.25
|
|
Extension No. 3 to $50,000 Term Note issued to C. Stephen Cochennet dated June 12, 2013 (incorporated by reference to Exhibit 10.25 to the Form 10-Q filed on August 14, 2013)
|
10.26
|
|
Extension No. 2 to $50,000 Term Note issued to C. Stephen Cochennet dated June 23, 2013 (incorporated by reference to Exhibit 10.26 to the Form 10-Q filed on August 14, 2013)
|
10.27
|
|
Extension No. 1 to $50,000 Term Note issued to Corey Lambrecht dated June 24, 2013 (incorporated by reference to Exhibit 10.27 to the Form 10-Q filed on August 14, 2013)
|
10.28
|
|
Extension No. 3 to $50,000 Term Note issued to C. Stephen Cochennet dated July 9, 2013 (incorporated by reference to Exhibit 10.28 to the Form 10-Q filed on August 14, 2013)
|
10.29
|
|
$50,000 Term Note issued to C. Stephen Cochennet dated August 12, 2013 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on August 21, 2013)
|
10.30
|
|
$100,000 Term Note issued to C. Stephen Cochennet dated August 26, 2013 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on September 5, 2013)
|
10.31
|
|
Form of 12% New Note and Warrant (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on October 4, 2013)
|
10.32
|
|
New Note issued to C. Stephen Cochennet (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on October 4, 2013)
|
10.33
|
|
New Note issued to James G. Miller (incorporated by reference to Exhibit 10.3 to the Form 8-K filed on October 4, 2013)
|
10.34
|
|
New Note issued to Corey Lambrecht (incorporated by reference to Exhibit 10.4 to the Form 8-K filed on October 4, 2013)
|
10.35
|
|
New Note issued to Jim Nolton (incorporated by reference to Exhibit 10.5 to the Form 8-K filed on October 4, 2013)
|
10.36
|
|
$50,000 New Note issued to C. Stephen Cochennet (incorporated by reference to Exhibit 10.6 to the Form 8-K filed on October 4, 2013)
|
10.37
|
|
$250,000 New Note issued to Kansas Resource Development Company (incorporated by reference to Exhibit 10.7 to the Form 8-K filed on October 4, 2013)
|
10.38
|
|
$30,000 New Note issued to James G. Miller (incorporated by reference to Exhibit 10.8 to the Form 8-K filed on October 4, 2013)
|
10.39
|
|
Form of 12% Note and Warrant (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on February 25, 2014)
|
10.40
|
|
$50,000 Note issued to James G. Miller (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on February 25, 2014)
|
10.41
|
|
$25,000 Note issued to Jim Nolton (incorporated by reference to Exhibit 10.3 to the Form 8-K filed on February 25, 2014)
|
10.42
|
|
$400,000 Note issued to C. Stephen Cochennet (incorporated by reference to Exhibit 10.4 to the Form 8-K filed on February 25, 2014)
|
10.43
|
|
Cornerstone Line of Credit Agreements (incorporated by reference to Exhibit 10.43 to the Form 10-K filed on March 28, 2014)
|
10.44
|
|
Extension No. 1 to $543,300.01 Term Note issued to C. Stephen Cochennet dated April 30, 2014 (incorporated by reference to Exhibit 10.44 to the Form 10-Q filed on May 15, 2014)
|
10.45
|
|
Extension No. 1 to $52,983.33 Term Note issued to James Miller dated April 30, 2014 (incorporated by reference to Exhibit 10.45 to the Form 10-Q filed on May 15, 2014)
|
10.46
|
|
Extension No. 1 to $52,650 Term Note issued to Corey Lambrecht dated April 30, 2014 (incorporated by reference to Exhibit 10.46 to the Form 10-Q filed on May 15, 2014)
|
10.47
|
|
Extension No. 1 to $45,000 Term Note issued to Jim Nolton dated April 30, 2014 (incorporated by reference to Exhibit 10.47 to the Form 10-Q filed on May 15, 2014)
|
10.48
|
|
Extension No. 1 to $50,000 Term Note issued to C. Stephen Cochennet dated April 30, 2014 (incorporated by reference to Exhibit 10.48 to the Form 10-Q filed on May 15, 2014)
|
10.49
|
|
Extension No. 1 to $250,000 Term Note issued to Kansas Resource Development Company dated April 30, 2014 (incorporated by reference to Exhibit 10.49 to the Form 10-Q filed on May 15, 2014)
|
10.50
|
|
Extension No. 1 to $30,000 Term Note issued to James Miller dated April 30, 2014 (incorporated by reference to Exhibit 10.50 to the Form 10-Q filed on May 15, 2014)
|
10.51
|
|
Form of Note Extension No. 1 dated April 30, 2014 (incorporated by reference to Exhibit 10.51 to the Form 10-Q filed on May 15, 2014)
|
10.52
|
|
Securities Purchase Agreement dated May 27, 2014 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on May 28, 2014)
|
10.53
|
|
Registration Rights Agreement dated May 27, 2014 (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on May 28, 2014)
|
10.54
|
|
Form of Secured Guaranty dated May 27, 2014 (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on May 28, 2014)
|
10.55
|
|
Form of Pledge and Security Agreement dated May 27, 2014 (incorporated by reference to Exhibit 10.3 to the Form 8-K filed on May 28, 2014)
|
10.56
|
|
Form of Class C Warrant (incorporated by reference to Exhibit 10.4 to the Form 8-K filed on May 28, 2014)
|
10.57
|
|
Senior Secured Debenture ($1,500,000) Wolverine Flagship Fund Trading Limited dated May 27, 2014 (incorporated by reference to Exhibit 10.5 to the Form 8-K filed on May 28, 2014)
|
10.58
|
|
Senior Secured Debenture ($1,000,000) Pinnacle Family Office Investments, L.P. dated May 27, 2014 (incorporated by reference to Exhibit 10.6 to the Form 8-K filed on May 28, 2014)
|
10.59
|
|
Senior Secured Debenture ($1,000,000) CK Management, LLC dated May 27, 2014 (incorporated by reference to Exhibit 10.7 to the Form 8-K filed on May 28, 2014)
|
10.60
|
|
Senior Secured Debenture ($750,000) Atlas Allocation Fund, L.P. dated May 27, 2014 (incorporated by reference to Exhibit 10.8 to the Form 8-K filed on May 28, 2014)
|
10.61
|
|
Senior Secured Debenture ($500,000) Calm Waters Partnership dated May 27, 2014 (incorporated by reference to Exhibit 10.9 to the Form 8-K filed on May 28, 2014)
|
10.62
|
|
Senior Secured Debenture ($250,000) Hard 4 Holdings LLC dated May 27, 2014 (incorporated by reference to Exhibit 10.10 to the Form 8-K filed on May 28, 2014)
|
10.63
|
|
Senior Secured Debenture ($100,000) Carl Feldman dated May 27, 2014 (incorporated by reference to Exhibit 10.11 to the Form 8-K filed on May 28, 2014)
|
10.64
|
|
Senior Secured Debenture ($50,000) Brett Luskin dated May 27, 2014 (incorporated by reference to Exhibit 10.12 to the Form 8-K filed on May 28, 2014)
|
10.65
|
|
Senior Secured Debenture ($50,000) Taylor Luskin dated May 27, 2014 (incorporated by reference to Exhibit 10.13 to the Form 8-K filed on May 28, 2014)
|
10.66
|
|
Senior Secured Debenture ($50,000) Cary Luskin dated May 27, 2014 (incorporated by reference to Exhibit 10.14 to the Form 8-K filed on May 28, 2014)
|
10.67†
|
|
Hanrahan Amendment No. 2 to Interim CFO Agreement dated May 22, 2014 (incorporated by reference to Exhibit 10.15 to the Form 8-K filed on May 28, 2014)
|
10.68
|
|
Senior Secured Debenture ($300,000) Southwell Capital, LP dated June 2, 2014 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on June 3, 2014)
|
10.69
|
|
Senior Secured Debenture ($250,000) Atlas Allocation Fund, L.P. dated June 2, 2014 (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on June 3, 2014)
|
10.70
|
|
Senior Secured Debenture ($225,000) Precept Capital Master Fund, GP dated June 2, 2014 (incorporated by reference to Exhibit 10.3 to the Form 8-K filed on June 3, 2014)
|
10.71
|
|
Senior Secured Debenture ($200,000) Sandor Capital Master Fund dated June 2, 2014 (incorporated by reference to Exhibit 10.4 to the Form 8-K filed on June 3, 2014)
|
10.72
|
|
Senior Secured Debenture ($125,000) The Precept Fund II, LP dated June 2, 2014 (incorporated by reference to Exhibit 10.5 to the Form 8-K filed on June 3, 2014)
|
10.73
|
|
Senior Secured Debenture ($100,000) James K. Price dated June 2, 2014 (incorporated by reference to Exhibit 10.6 to the Form 8-K filed on June 3, 2014)
|
10.74
|
|
Senior Secured Debenture ($80,000) Vestal Venture Capital dated June 2, 2014 (incorporated by reference to Exhibit 10.7 to the Form 8-K filed on June 3, 2014)
|
10.75
|
|
Senior Secured Debenture ($50,000) Helmsbridge Holdings Limited dated June 2, 2014 (incorporated by reference to Exhibit 10.8 to the Form 8-K filed on June 3, 2014)
|
10.76
|
|
Senior Secured Debenture ($50,000) JSL Kids Partners dated June 2, 2014 (incorporated by reference to Exhibit 10.9 to the Form 8-K filed on June 3, 2014)
|
10.77
|
|
Senior Secured Debenture ($52,680.82) Cranshire Capital Master Fund, Ltd. dated June 13, 2014 (incorporated by reference to Exhibit 10.77 to the Form S-1 filed on August 29, 2014)
|
10.78
|
|
Senior Secured Debenture ($170,000) C. Stephen Cochennet dated June 2, 2014 (incorporated by reference to Exhibit 10.11 to the Form 8-K filed on June 3, 2014)
|
10.79
|
|
Senior Secured Debenture ($50,000) James G. Miller dated June 2, 2014 (incorporated by reference to Exhibit 10.12 to the Form 8-K filed on June 3, 2014)
|
10.80
|
|
Senior Secured Debenture ($25,000) Corey Lambrecht dated June 2, 2014 (incorporated by reference to Exhibit 10.13 to the Form 8-K filed on June 3, 2014)
|
10.81
|
|
Senior Secured Debenture ($20,372.60) Nolton Enterprises dated August 26, 2014 (incorporated by reference to Exhibit 10.81 to the Form S-1 filed on August 29, 2014)
|
10.82
|
|
Senior Secured Debenture ($10,000) William Clough dated June 2, 2014 (incorporated by reference to Exhibit 10.15 to the Form 8-K filed on June 3, 2014)
|
10.83
|
|
Senior Secured Debenture ($10,000) Kathleen Hanrahan dated June 2, 2014 (incorporated by reference to Exhibit 10.16 to the Form 8-K filed on June 3, 2014)
|
10.84
|
|
Senior Secured Debenture ($10,000) Kyle Edwards dated June 2, 2014 (incorporated by reference to Exhibit 10.17 to the Form 8-K filed on June 3, 2014)
|
10.85
|
|
Senior Secured Debenture ($22,500) Equitec Specialists, LLC dated June 13, 2014 (incorporated by reference to Exhibit 10.85 to the Form S-1 filed on August 29, 2014)
|
10.86†
|
|
|
31.1
|
|
|
31.2
|
|
|
32.1
|
|
|
32.2
|
|
|
99.1
|
|
Code of Business Conduct and Ethics effective March 23, 2012 (incorporated by reference to Exhibit 99.1 to Form 10-K filed on March 29, 2012)
|
99.2
|
|
Related Party Transaction Policy effective March 23, 2012 (incorporated by reference to Exhibit 99.1 to Form 10-K filed on March 29, 2012)
|
99.3
|
|
Executive Committee Charter (incorporated by reference to Exhibit 99.1 to Form 10-K filed on March 23, 2011)
|
99.4
|
|
Audit Committee Charter (incorporated by reference to Exhibit 99.2 to Form 8-K filed on April 30, 2012)
|
99.5
|
|
Governance, Compensation and Nominating Committee Charter (incorporated by reference to Exhibit 99.3 to Form 8-K filed on April 30, 2012)
|
99.6
|
|
Corporate order press release dated July 30, 2013 (incorporated by reference to Exhibit 99.11 to the Form 10-Q filed on August 14, 2013)
|
99.7
|
|
Security Industry Sales press release dated August 6, 2013 (incorporated by reference to Exhibit 99.12 to the Form 10-Q filed on August 14, 2013)
|
99.8
|
|
Zacks Research Report dated September 13, 2013 (incorporated by reference to Exhibit 99.1 to the Form 8-K filed on September 13, 2013)
|
99.9
|
|
Training Program Press Release dated September 5, 2013(incorporated by reference to Exhibit 99.14 to the Form 10-Q filed on November 14, 2013)
|
99.10
|
|
ASIS 2013 Exhibition Press Release dated September 19, 2013 (incorporated by reference to Exhibit 99.15 to the Form 10-Q filed on November 14, 2013)
|
99.11
|
|
Production Increase Press Release dated October 4, 2013 (incorporated by reference to Exhibit 99.16 to the Form 10-Q filed on November 14, 2013)
|
99.12
|
|
Nova Security Group Distributor Agreement Press Release dated October 14, 2013 (incorporated by reference to Exhibit 99.17 to the Form 10-Q filed on November 14, 2013)
|
99.13
|
|
Presentation as of December 2013 (incorporated by reference to Exhibit 99.1 to the Form 8-K filed on December 3, 2013)
|
99.14
|
|
Private Placement Closing Press Release dated November 21, 2013 (incorporated by reference to Exhibit 99.2 to the Form 8-K filed on December 3, 2013)
|
99.15
|
|
LD Micro Event Press Release dated November 27, 2013 (incorporated by reference to Exhibit 99.3 to the Form 8-K filed on December 3, 2013)
|
99.16
|
|
CALSAGA Strategic Alliance Press Release dated January 8, 2014 (incorporated by reference to Exhibit 99.16 to the Form 10-Q filed on May 15, 2014)
|
99.17
|
|
Cornerstone Bank Line of Credit Press Release dated January 22, 2014 (incorporated by reference to Exhibit 99.17 to the Form 10-Q filed on May 15, 2014)
|
99.18
|
|
Russia and Mexico Distributor Press Release dated February 4, 2014 (incorporated by reference to Exhibit 99.18 to the Form 10-Q filed on May 15, 2014)
|
99.19
|
|
Additional Sales Representatives Press Release dated February 6, 2014 (incorporated by reference to Exhibit 99.19 to the Form 10-Q filed on May 15, 2014)
|
99.20
|
|
ENL Letter of Intent to Securitas Press Release dated February 27, 2014 (incorporated by reference to Exhibit 99.20 to the Form 10-Q filed on May 15, 2014)
|
99.21
|
|
Hospital Staff Accolade Press Release dated March 31, 2014 (incorporated by reference to Exhibit 99.21 to the Form 10-Q filed on May 15, 2014)
|
99.22
|
|
Hospital Usage Press Release dated April 3, 2014 (incorporated by reference to Exhibit 99.22 to the Form 10-Q filed on May 15, 2014)
|
99.23
|
|
Clough Appointment Press Release dated April 15, 2014 (incorporated by reference to Exhibit 99.1 to the Form 8-K filed on April 15, 2014)
|
99.24
|
|
Large Public Venue Press Release dated April 23, 2014 (incorporated by reference to Exhibit 99.24 to the Form 10-Q filed on May 15, 2014)
|
99.25
|
|
$7 million financing Press Release dated June 2, 2014 (incorporated by reference to Exhibit 99.25 to the Form 10-Q filed on August 14, 2014)
|
99.26
|
|
Platinum Event Services Press Release dated June 17, 2014 (incorporated by reference to Exhibit 99.24 to the Form 10-Q filed on August 14, 2014)
|
99.27
|
|
|
99.28
|
|
|
99.29
|
|
|
99.30
|
|
|
99.31
|
|
|
101.INS
|
|
XBRL Instance Document
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
† Indicates management contract or compensatory plan or arrangement.
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
GUARDIAN 8 HOLDINGS
(Registrant)
|
|
|
|
|
|
Date: November 14, 2014
|
By:
|
/s/ C. Stephen Cochennet
|
|
|
|
C. Stephen Cochennet
|
|
|
|
Chief Executive Officer
|
|
|
|
(On behalf of the Registrant and as Chief Executive Officer)
|
|
|
|
|
|
Date: November 14, 2014
|
By:
|
/s/ Kathleen Hanrahan
|
|
|
|
Kathleen Hanrahan
|
|
|
|
Chief Financial Officer
|
|
|
|
(On behalf of the Registrant and as Principal Financial Officer)
|
|